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New discoveries in the realm of biology often come hand-in-hand with 
innovations in technology. Over the last two decades, advancements in 
microfabrication and microscopy have opened biological phenomena to be 
studied in fundamental units rather than as a collective entity. From these 
efforts, the axioms upon which we built our fundamental concepts in anatomy 
and physiology have been reshaped. We now understand that even within a 
subpopulation of cells taken from the same tissue, cell-to-cell variations exist in 
both phenotypic and genotypic expression. These variations are found to play 
critical roles in disease state and progression, thus, research into single cells and 
single molecules are a necessity to improving treatment.  
In this work, methods of single molecule analysis of native human 
chromatin fibers are presented as well as methods and devices for multi- and 
single cell genome analysis. As the handling of single molecules and single cells 
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are facilitated by microfabricated devices, discussed herein are their designs, 
fabrication methods, operational procedures, working principles, and 
experimental results representative of their biologically relevant impact. Our 
findings point towards potential platform technologies in high-throughput 
chromatin linearization for fluorescence based epigenetic mapping and single 
cell whole genome amplification with reduced amplification bias and improved 
genome coverage.  
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CHAPTER 1 
OVERVIEW 
 
DNA, widely regarded as the fundamental building block of life, has been 
extensively studied as both a physical molecule as well as an information carrier 
for nearly a century. Only recently have advances in micro- and 
nanotechnology allowed us to precisely characterize and probe the information 
contained within DNA. These advancements have led to the understanding that 
not only are heritable chemical modification of the genome important to gene 
regulation and gene expression, but that each individual cell can differ from one 
another within a tissue type. However, studying these phenomena requires 
new tools to be developed. To this end, the microfabricated technologies we 
have developed to improve upon existing methods are presented.  
 
Chapter 2 covers the motivations behind developing methods for chromatin 
linearization and imaging by describing the basic principles of epigenetics and 
 existing methods of epigenetic analysis. We then discuss recent advances in 
epigenetic analysis and chromatin linearization before moving into Chapter 3, 
where we describe in detail our own technique producing ordered arrays of 
native chromatin using molecular combing and transfer printing. Together 
Chapters 2 and 3 mark part I of this dissertation. 
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Part II begins with Chapter 4, where microfluidic based cell processing devices 
are analyzed for their benefit unique advantages in handling few and single 
cells. We present our device, a simple, valveless, micropillar array based device 
cast from PDMS designed for cell capture, lysis, and DNA extraction. In this 
chapter, we characterize various parameters of the device and assess for DNA 
capture efficiency of multiple and single cells.  
 
This work then segues into Chapter 5, where we examine single cell 
technologies in more detail as compared to our device. By redesigning the 
micropillar array device for single cell capture, we utilize the device as a 
platform for on-chip whole genome amplification.  
 
Finally, Chapter 6 is where we discuss future directions for the microfluidic 
device and potential experiments that will demonstrate the unique advantages 
conferred by our chip as a DNA amplification platform device as compared to 
existing single cell technologies.  
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CHAPTER 2   
EPIGNETICS AND DNA LINEARIZATION 
 
 
2.1  INTRODUCTION TO CHROMATIN AND EPIGENETICS 
 
With roughly 3 billion bases comprising the human genome, the DNA from a 
single cell would span nearly 2 meters in length if stretched out from end to 
end.[1] In order for all of this DNA to be packaged within the cell nucleus, DNA 
exists in eukaryotic cells as a part of chromatin. Chromatin refers to the higher 
order structures of DNA wrapped around histone protein complexes. 
Comprised of an octamer formed by histone proteins H2A, H2B, H3, and H4, 
the histone core complex is bound together by 146 bases of DNA with the help 
of linker protein histone H1.[2] Together, this structure forms what is known as 
a nucleosome, the fundamental repeating unit by which chromatin is built. 
Between each nucleosome are segments of linker DNA that range in length from 
tens of bases up to several kilobases.[3] 
 
However, rather than remaining fixed in a permanent configuration, chromatin 
is a dynamic molecule constantly undergoing conformational changes as 
cellular processes such as gene transcription and cellular division occurs. 
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Known as chromatin remodeling, the chromatin hierarchal structure acts as a 
controller mechanism for gene regulation by physically modulating 
accessibility of the genome to transcription related proteins such as RNA 
polymerase and transcription factors.[4] If a gene promotor region is 
inaccessible due to the structure of the local chromatin, RNA polymerase is 
unable to initiate transcription and form an open complex. In such cases, 
messenger RNA (mRNA) for a particular gene would be unable to be 
transcribed and subsequently translated into a given protein even though the 
gene for such a protein exists within the genome. This is the case for 
heterochromatin, a tightly wound configuration of chromatin that consists of 
inactivate gene sites and telomeres packaged into tertiary order 30nm diameter 
fibers with the help of histone H1 and is heavily localized to the walls of the cell 
nucleus. The existence of heterochromatin has been suggested to serve roles of 
chromatin preservation as well as epigenetic inheritance.[5-6] In contrast to 
heterochromatin, euchromatin is a much more accessible conformation of 
chromatin containing actively transcribed genes and nucleosomes loosely 
configured in a “beads-on-a-string” format. Euchromatin represents the default 
configuration for the vast majority of the human genome and unlike 
heterochromatin, euchromatin is active in gene transcription.[7]  
 
5 
 
The mechanisms by which chromatin remodeling form heterochromatin versus 
euchromatin are controlled through a set of covalent modifications. These 
modifications can exist in the form of DNA methylation, hydroxymethylation, 
and oxidation or histone modifications in the form of acetylation, methylation, 
phosphorylation, and ubiquitination. Collectively, these chemical 
modifications are referred to as the epigenetic state or the epigenome of a cell. 
Research into epigenetics have revealed the critical relation between 
epigenomics and disease. In humans, numerous conditions including heart 
disease, autism, obesity, and various forms of cancer have been found to be 
correlated to epigenetic states and modifications.[8-10]  
 
A prominent example of one such type of correlation is with CpG island 
hypermethylation. Denoting a repetitive sequence of cytosine bases and 
guanine bases connected via the DNA phosphate backbone, CpG sites can 
cluster into high density within the genome regions known as CpG islands that 
range in size from hundreds of bases up to a few kilobases. The importance of 
CpG islands is that in humans, 60% of gene promotor regions contain CpG 
islands.[11] As such, hypermethylation of cytosines within CpG islands can 
lead to gene silencing.[12-13] For example, when genes such as MLH1 or 
BRCA1 are suppressed via this process, cancer onset can occur resulting in 
colon or breast cancers respectively.[14-15] Furthermore, suppressing 
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transcription via DNA hypermethylation can lead to hosts of other diseases 
including those of neurological and autoimmune pathogenesis.[8]  
 
Consequently, an active area of medicine aims to improve our understanding 
of the epigenome and its ability to affect health and disease states. Efforts in this 
field contribute towards mapping the human epigenome and the complex 
relations between epigenetic modifications and disease. In the future, with the 
epigenome mapped and a fuller understanding of the ties between various 
epigenetic modifications and diseases, the opportunity to create diagnostics 
and eventually even therapeutics based on the epigenome may come to light.  
 
 
2.2  PRIMER ON EPIGENETIC MAPPING 
 
Currently, the standard in epigenetic mapping utilizes two techniques in 
conjunction with DNA sequencing. The first is bisulfite sequencing, which is 
used to map DNA methylation positions on the genome, and the second is 
chromatin immunoprecipitation (ChIP) which is used to map the location of 
specific histone modifications on the genome. The cornerstone of bisulfite 
sequencing based epigenetic mapping techniques rely on converting 
unmethylated cytosine bases into uracils through sulfonating the cytosine 
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molecule, hydrolytic deamination, and finally desulfonation. This process, 
however, is disrupted in the presence of 5’ methylation. In such cases, a CH3 
methyl group binds to the 5-prime position carbon atom on the cytosine 
molecule preventing the sulfonation of the molecule. Thus, sodium bisulfite 
converts all non-methylated cytosine bases into uracils while methylated 
cytosines remain. Through subsequent DNA amplification and sequencing, the 
sequence of bisulfite converted DNA can be compared to the sequence of 
identical genome regions that have not been bisulfite converted to determine 
the genomic positions of cytosine methylation.  
 
On the other hand, in ChIP based sequencing (ChIP-seq), native chromatin is 
chemically treated with formaldehyde to crosslink histone complexes to the 
local DNA. The DNA is then fragmented either physically as with sonication or 
enzymatically. Histone modifications of interest are then selected from the 
suspension of nucleosomes by binding epigenetic modifications of interest to 
substrates or particles functionalized with target-specific antibodies. The 
arrested nucleosomes containing histone modifications of interest are then 
isolated from solution and purified. This process is referred to as 
immunoprecipitation. The chromatin is eluted from the beads via heat 
denaturation and the DNA that is bound to the nucleosomes are then unlinked 
from the histone proteins with the help of proteinases such as proteinase K. The 
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released DNA represents the genome location of the histone modifications 
selected by immunoprecipitation and can be sequenced to map the epigenetic 
mark back onto the reference genome. 
 
Although both of epigenome mapping approaches offer unique advantages, the 
utilities of each are far from sufficient for use in clinical diagnostics. One such 
shortcoming of these two techniques is that although they offer a high degree 
of accuracy, they are considerably time consuming and require on the order of 
millions of cells.[16] Despite recent advances that allowed both ChIP-seq and 
bisulfite sequencing to reliably operate from only a few thousand cells, the 
sensitivity limits of both techniques still bar them from being used in low-cell 
count scenarios.[17] For example, cancer metastasis is initiated by aggressively 
mobile cancer cells within the body known as circulating tumor cells (CTC). 
These rare cells often exist at ultralow concentrations of less than 10 cells per 
milliliter of whole blood.[18] Hence, determining the epigenetic behavior of 
patient CTCs remains highly challenging not only from the perspective of 
capturing the CTCs but also in terms of analysis methods with enough 
sensitivity.  
 
Furthermore, there are fundamental limitations to ChIP-seq and bisulfite 
sequencing that cannot be removed by optimization of current protocols. ChIP-
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seq is limited in only being able to serially interrogate one subset of histone 
modifications at a time. The information from nucleosomes containing multiple 
sets of epigenetic modifications would be lost in immunoprecipitation. 
Similarly, bisulfite sequencing can offer high resolution methylation mapping, 
however, the dynamic behavior of the epigenetic state is lost in both analysis 
methods as they require permanent alteration of the template genomes such as 
crosslinking and fragmentation in immunoprecipitation and DNA degradation 
in sodium bisulfite conversion. In this vein, exploring alternative epigenetic 
mapping techniques are critical to the overall development of epigenomics-
based diagnostics. One such alternative to ChIP-seq and bisulfite sequencing is 
to probe for epigenetic marks of interest directly on the genome with the aid of 
technologies from the field of nanobiotechnology.[16,19] 
 
 
2.3  SURVEY OF DNA & CHROMATIN LINEARIZATION TECHNIQUES 
 
Itself an eclectic field derived from the broader field of biophysics, 
nanobiotechnology has made significant impacts in the biological research since 
its inception half a century ago. Over the last three decades, advancements in 
micro- and nanofabrication have allowed scientists to begin analyzing 
biological phenomena at its most fundamental level: single molecules. The 
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power of using high-resolution single molecule techniques to directly 
interrogate epigenetic marks on the genome without needing to destroy or alter 
the genome confers several advantages over methods such as ChIP and bisulfite 
sequencing, which can only indirectly infer the epigenetic state at hand. In this 
section, several established methods for single molecule handling of DNA and 
chromatin are evaluated for their individual strengths and weaknesses in 
application towards epigenetic mapping. 
 
 
2.3.1  Magnetic and Optical Tweezers 
 
Using either magnetic forces or optical traps to micromanipulate beads tethered 
to DNA molecules, magnetic and optical “tweezers” have been used to study 
the mechanical properties of DNA as early as 1992 and 1996 respectively by 
Smith S. B. et al.[20-21] Briefly, magnetic tweezers use magnetized 
microparticles that are surface functionalized with proteins such as 
streptavidin, which forms a strong bond to biotin. Biotin can then be hybridized 
the end of a chromatin or DNA molecule. Either one or both ends of the 
biological molecule can be tethered to a bead or a planar surface and the bead 
can be manipulated with the magnetic field created by a set of permanent 
magnets. Repositioning the magnets allows for rotational and directional 
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control over the magnetic microparticle which translates into forces acted upon 
the biological molecule. In similar fashion, optical tweezers also rely on a 
protein-protein interaction to anchor the biological molecule to a microsphere. 
However, rather than relying on a magnetic field, a laser is focused through a 
high numerical aperture objective lens creating a narrow beam waist that is able 
to impart the momentum of scattered incident photons onto a dielectric 
microparticle.  
 
 
 
 
Figure 2.1 – Illustration of Force Measurement Experiments Performed with 
Magnetic and Optical Tweezers 
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(Modified from Fierz B., 2016) 
(A) Magnetic microsphere coated with streptavidin can be tethered to a chromatin with 
a biotinylated end. By pulling the microsphere directionally along the z-axis, (B) 
chromatin fiber thickness can be measured as a function of the length of DNA linkers 
between nucleosomes until all nucleosomes have been pulled off. (C) The principles of 
Fluorescence Resonance Energy Transfer (FRET) can be used to monitor separation 
between the two points to denote nucleosome unraveling. As force is increased, the 
distance between two FRET molecules grows thereby lowering the fluorescence 
intensity of the pairing. 
 
Both optical and magnetic tweezers offer the advantage of being able to 
elongate DNA or chromatin with a high degree of control in the force applied 
to the molecule.[22] With sub-pN force resolution, past research has used 
tweezer-based methods to determine contour length of DNA, measure tensile 
forces of single nucleosomes, measure forces required to unzip double stranded 
DNA, alter the conformational state of single chromatin molecules through 
elongation, and make real-time observations of protein dynamics.[23-24] 
Examples of the workflow of a few such studies are illustrated in figure 2.1 
above.[24] Unfortunately, tweezer based methods are at a disadvantage when 
conjugating microspheres to unknown sequences such as native chromatin 
from cells. To date, the most apt demonstration of using optical tweezers to 
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elongate native chromatin was done by Oana H. and colleagues in 2014 as 
shown in figure 2.2 below.[25] In this study, authors relied on functionalizing 
histones to tether the chromosome to the dielectric microparticle, which 
precluded the ability to image chromosome molecules without folding over of 
the chromosome at the tethered end. 
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Figure 2.2 – Optical Tweezer Based Elongation of Single Chromatin Fibers 
via Microsphere Anchoring to PDMS Posts 
(Adapted from Oana H. et. al., 2014) 
Cells are lysed within a triangular compartment in microfluidic device. Functionalized 
microspheres that bind non-sequence specifically are used to fish out and maneuver the 
chromatin. (A) Long chromatin fibers are easily entangled during translocation and 
become difficult to pass through twin polydimethylsiloxane (PDMS) posts designed to 
anchor the microsphere. (B) An alternative design where less entangled chromatin is 
looped around a single pillar due to the difficulty in directing a long fiber through gap 
between two close-set microposts.  
 
All-in-all, although tweezer-based studies have been substantial to the overall 
understanding of DNA structure, nucleosome mechanical properties, and 
DNA-protein dynamics, optical and magnetic tweezers face many challenges 
including ultra-low throughput and limited molecule lengths when considered 
as a tool for epigenetic mapping.  
 
 
2.3.2  Nanopore Based Technologies 
 
The essence of nanopore based technologies can be described as using voltage 
differentials to translocate DNA or chromatin through a hole on a thin dielectric 
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membrane and measuring changes in the electrical signal of the substrate to 
determine the local structure of the molecule as it passes through. Since 
different nucleic acid bases translocate at different speeds and impede the ionic-
current to differing degrees, nanopore technologies are used as a method of 
sequencing of DNA and RNA. Although it widely accepted that pore sizes 
should prevent looping events from traversing the pore during sequencing, 
there has yet to be an established standard optimal pore size.[26] As the spatial 
resolution of nanopore technologies depend on both the thickness of the 
membrane and size of the pore, researchers have made efforts to reduce 
membrane thicknesses of various solid-state nanopores down to sub-
nanometer thick silicon nitride and even single-atom layer graphene 
membranes.[26-28] Transmembrane proteins such as α-hemolysin, MspA, and 
Phi29 are commonly used to create biological pores and in recent years, they 
have been incorporated onto solid-state membranes to form hybrid nanopore 
devices. The advantage of using biological pores is improved signal-to-noise 
ratio over solid-state pores that can experience high noise levels. This improved 
signal can be further facilitated by the ratcheting function of the proteins such 
as Phi29 to modulate the speed of DNA translocation through the pore.[29-30]  
 
Even more recently, DNA methylation has been observed with the use of 
nanopore based technologies. In a study done by Shim. J. et. al. in 2013, methyl-
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binding domain protein-1 (MBD1) was used to label methylation sites along a 
strand of methylated DNA.[31] The translocation current of the MBD1-labeled 
DNA was than measured as it was passed through a 12 nm diameter solid-state 
pore in 20nm thick silicon nitride. The results of this experiment showed the 
ability to differentiate unmethylated DNA from their control samples versus 
methylated DNA with high fidelity. However, the authors are unable to recount 
the exact number of methylation sites as translocation speed still proves to be 
an issue regarding reading spatial resolution of the DNA molecule. Molecular 
dynamic simulations have proposed functionalizing the inner pore edges with 
DNA bases to improve sequencing accuracy and slow DNA translocation times, 
but these theories have yet to see any validity experimentally.[28] Furthermore, 
removing DNA interactions with the membrane wall at the pore interface still 
presents a challenge.[28,32,35] Localized non-covalent blocking has been 
proposed, but has yet to see widespread use.[33,36] Finally, although proof of 
concept experiments such as those from Soni G. V. and colleagues have shown 
the ability to differentiate between mononucleosomes versus dinucleosomes 
using 20nm diameter pores in silicon nitride, longer chromatin molecules have 
not been demonstrated to be passed through nanopores for identifying or 
mapping epigenetic marks.[34] Consequently, although nanopore technologies 
represent a time-efficient means of analyzing methylation marks, it in DNA, 
much work has yet to be done before nanopores can be used as a basis for 
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epigenetic mapping. The possibility of simultaneous methylation detection and 
DNA sequencing has not been evidenced and longer chromatin reads are not 
yet possible.  
 
 
2.3.3  Nanochannel and Confinement Technologies 
 
Through using physical barriers to spatially confine DNA and chromatin 
molecules into linear orientations, nanochannel and nanoconfinement based 
technologies have emerged as feasible approach to directly interrogating 
epigenetic marks of interest. Generally, this involves labeling DNA or 
chromatin with fluorescent tags specific to epigenetic marks of interest and 
using high resolution imaging to determine the position of an epigenetic event 
on the molecule. This positional information relative to the DNA or chromatin 
molecule can then be transposed back the genome to determine the absolute 
position of the epigenetic event given the underlying molecule sequence.[37-40] 
 
Though there exist many approaches to nanochannel manipulation of DNA or 
chromatin, several in particular have been demonstrated to be applicable 
towards the direct detection and imaging of epigenetic marks on either DNA or 
chromatin. One such demonstrates the use of electrophoretic flow to drive 
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100kb-length DNA into 45nm straight channels. Using a series of micropillars 
in front of the channel entrance to disentangle the DNA, the molecules remain 
linearized due to the sub-persistence length diameter (50nm in DNA) of the 
nanochannels.[41] In this study, sequence specific nicking sites are used to label 
the DNA to which the optically measured length between labels can be 
correlated to a sequence-specific position due to enzyme recognition sites used. 
The genomic position of fluorescently tagged marks, in this case major 
histocompatability complexe (MHC) sites, can then be determined after piecing 
together fragments using overlapping regions as shown in figure 2.3 below.[42] 
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Figure 2.3 – Imaging and Mapping MHC sites on BACs in Nanofabricated 
Channels 
(Modified from Lam E.T. et. al., 2012) 
(A) DNA labeled with YOYO-1 intercalating dye demonstrates DNA’s ability to enter 
nanochannels after micropillar facilitated disentanglement (Micropillars not 
highlighted). (B) Nick-labled MHC sites (green) on DNA backbone (blue) while the 
DNA is traversing the channel via electrophoretic flow. (C) DNA fragments are 
elongated to 85% of their theoretical length. Longest fragment size reaches up to 250kb. 
(D) MHC locations for each fragment can be mapped and stitched back together via 
overlapping regions. 
 
While this is an elegant demonstration of high-resolution imaging based DNA 
mapping, the above nanochannels are far less compatible when applied to 
chromatin as protein-surface interactions can often cause clogging in 
electrophoretic flow based nanochannels. Furthermore, fixed nanochannel 
dimensions do not reflect the higher complexity of chromatin. For instance, 
chromatin flexibility and persistence lengths vary based on histone 
modifications and irregularities in nucleosome folding. An alternative 
approach to confine and elongate chromatin.[43] Demonstrated by Matsuoka T. 
and colleagues in 2012, figure 2.4, capitalizes on the deformability PDMS to 
elongate chromatin by the action of constricting channel width.[44] By pulling 
axially on a 122nm diameter PDMS nanochannel, a combination of shear forces 
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and reduced entropic freedom was used to elongate λ-DNA to 97% of its 
contour length. This technique was then applied to diamidino phenylindole 
(DAPI) stained HeLa-GFP chromatin labeled with histone H4 acetylation 
(H4ac) antibody. The H4ac marks are then mapped to histone positions and the 
underlying DNA. 
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Figure 2.4 – PDMS Nanoconfinement Device for Chromatin Elongation and 
Epigenetic Mapping 
(Modified from Matsuoka T. et. al., 2012) 
(A) As the PDMS nanochannel is extended axially, the constricting channel width 
causes elongation of HeLa-GFP chromatin molecules within the channel. A proof of 
concept type experiment is shown in (B) where histone H4 acetylation labeled with 
Anti-H4 antibody and mapped to the position of green fluorescent protein (GFP) 
fluorescent nucleosomes and the underlying DNA stained by DAPI. 
 
Authors in the above study observe that even when DNA is extended to over 
80% of its contour length, less than 35% of the DNA will be fully extended. The 
majority of molecules contain a knot either in the form of a dumbbell at one of 
the distal end of the molecule or a kink proximal to the center. This suggests 
that reliable extension of chromatin may not be guaranteed. Hence, the 
advantages of high-throughput nanochannel techniques may be more suited 
for genetic or epigenetic analysis of bare DNA as opposed to chromatin. 
 
 
2.3.4  Surface Immobilization Technologies 
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In contrast to nanochannel and confinement type technologies, surface 
immobilization technologies are not prone to non-specific binding induced 
channel clogging and therefore favorably suited to process and handle native 
chromatin. Techniques in surface immobilization of DNA date back to the mid-
1990s with work from Schwartz D. C. and colleagues where the interface of a 
drying droplet was used to elongate λ-DNA on a silanized glass surface.[45-46] 
With restriction endonuclease BamHI, they created nick sites without 
perturbing the elongated orientation of the molecules in a proof-of-concept 
experiment towards using surface immobilization of as a tool for genetic 
mapping. Bensimon A. and colleagues showed a similar capacity to elongate 
DNA by slowly vertically lifting a silanized glass slide from a beaker containing 
DNA in solution.[47-49] This process, known as molecular combing, aligns 
molecules perpendicular to the edge of a receding liquid meniscus. As 
demonstrated by Labit H. et al in 2008, figure 2.5, fluorescence in-situ 
hybridization (FISH) probes for specific sequences can be hybridized onto 
surface immobilized combed-DNA for genetic mapping. However, although 
this method has been applied in various instances of mapping DNA, it has yet 
to be applied to the mapping native euchromatin. 
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Figure 2.5 – FISH Labeling of λ-DNA Surface-Immobilized by Molecular 
Combing 
(Modified from Labit H. et. al., 2008) 
(A) DNA in solution is elongated at the liquid-to-air interface as a silanized glass 
coverslip is lifted from the solution at a constant velocity of 300 μm s-1. (B) Micrographs 
of immobilized λ-DNA stained with YOYO-1 intercalating dye. The DNA is combed 
into coiled, kinked, looped, and fully elongated configurations depending on surface 
treatment. (C) Repeating unit labeled by rDNA FISH probes to demonstrate 
fluorescence mapping. The length of the probes measured in the micrographs 
corresponds to the known length of the probes. 
 
Lastly, mapping has been demonstrated via non-immobilization based surface 
linearization. Using a lipid bilayer to generate a fluid surface, biotinylated DNA 
molecules can be end-tethered to select lipids. The resulting tethered molecule 
is free floating when placed solution but under hydrodynamic flow, the 
molecules can be pulled and elongated in the direction of flow. Coupling this 
principle with microfabricated barriers on the bilayer surface, molecules 
flowing downstream can be anchored along the barrier and linearized in a 
highly parallel fashion. This technique, known as DNA curtains, allows for a 
high throughput means of imaging DNA. Recently, the technique has been 
demonstrated in application with reconstituted chromatin to study nucleosome 
distribution as shown in figure 2.6.[50]   
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Figure 2.6 – Visualizing Nucleosomes on Reconstituted λ-DNA Using the 
Curtains Linearization Technique 
(Adapted from Visnapuu M. L. et. al., 2009) 
(A) Experimental overview of curtains linearization applied to chromatin. λ-DNA 
reconstituted chromatin is tethered to the lipid bilayer via a biotin-neutravidin 
interaction and hydrodynamic forces elongate the molecule in the direction of flow. (B) 
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Micrographs depicting chromatin molecules with quantum-dot labeled nucleosomes 
(pink) and YOYO-1 intercalating dye labeled DNA backbone (green). 
 
Even though the authors above demonstrate the high degree of parallelization 
conferred by the curtains technique on reconstituted chromatin, there are 
inherent disadvantages to the technique when considering native chromatin. 
Akin to the obstacles faced by using tweezer based methods for chromatin 
elongation, techniques that require biotin conjugation are less suitable when the 
sequence of the DNA or chromatin molecule of interest is unknown.  
 
 
2.4 CONCLUSION 
 
Here, techniques used for elongation and linearization of DNA and chromatin 
as it is applied to genetic and epigenetic mapping have been outlined. 
Collectively, these techniques preliminarily demonstrate the potential of direct 
interrogation of the genome. Each category of technologies described confer a 
set of advantages over indirect analysis methods such as ChIP-seq or bisulfite 
sequencing, however, these are often niche improvements that come as 
tradeoffs to existing capabilities.  
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Tweezer based methods offer the highest degree of control over a molecule of 
interest, making it appropriate for studying sensitive mechanical and structural 
forces of DNA or chromatin, but suffers from extremely low throughput and 
inability to end-tether a nucleic acid molecule of unknown sequence. On the 
other hand, methods such as DNA curtains offer a much higher throughput, 
able to visualize thousands of molecules on a single device, yet still require a 
known sequence to end-tether the DNA or chromatin strand. Nanochannel, 
nanopores, and nanoconfinement can load a DNA or chromatin molecule of any 
sequence, but each suffers from its own shortcomings. Nanochannels and 
nanopores are prone to clogging resulting from non-specific protein 
interactions whereas fully extending molecules via nanoconfinement is a 
Poisson dependent process.  
 
Furthermore, most techniques have only been demonstrated with DNA rather 
than chromatin. Of the techniques that have demonstrated their application 
with chromatin, fewer still have done so with native chromatin as opposed to 
reconstituted chromatin. Current challenges in working with native chromatin 
are numerous, including the extraction of long native chromatin strands and 
high throughput sequence independent elongation. In the chapter following, 
we expand upon molecular combing as a basis for elongation of native 
chromatin and imaging epigenetic marks via fluorescence labeling.  
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CHAPTER 3   
IMAGING EPIGENETIC MARKS ON DNA AND CHROMATIN ARRAYS 
 
 
3.1 INTRODUCTION 
 
In the previous chapter, we reviewed current standard techniques in epigenetic 
mapping as well as emerging techniques based on high resolution imaging of 
fluorescently labeled marks to directly interrogate the epigenetic landscape of 
a DNA or chromatin molecule. Of the techniques reviewed, few were suitable 
for native chromatin due to the complexity of extracting long, intact 
mammalian chromatin molecules of unknown sequence and then elongating it 
with high throughput methods. Here, we discuss the process of ultra-long 
native chromatin extraction from mammalian cells and subsequent elongation, 
immobilization, and finally, epigenetic labeling and imaging of the native 
chromatin.  
 
Techniques such as fluorescence in-situ hybridization (FISH) has long been 
used to fluorescently label target sequences on chromosome molecules.[1-3] 
The basic working principle of FISH is to use a target specific DNA probe that 
has been fluorescently labeled through processes such as nick translation, 
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where DNA polymerases are used to shift a DNase induced nick to allow for 
the insertion of fluorescent tags. This fluorescent DNA probe is then hybridized 
to a target sequence within a chromosome or segment of DNA and marks it 
with the specified fluorescence signature. Numerous applications have arisen 
out of FISH such as diagnosing chromosomal aberrations, interphase 
characterization for cytogenetics, monitoring disease progression, identification 
of translocation break points, gene mapping, and even painting whole 
chromosomes.[4-16] With the introduction of molecular combing by Bensimon 
et. al. in 1990s, molecular combing has improved the resolution of FISH based 
mapping down to 1 kb.[17-18] 
 
More recently, the process of molecular combing has been further optimized 
with the advent of microfabrication. One such improvement involves the use of 
photolithography to generate a pattern from which an array of microwells can 
be mold-casted. This microwell array can then serve in controlling the 
positioning of molecules being combed across the surface to achieve an ordered 
array. This ordered array patterning lends to improved image analysis and 
potential automation with regular spacing between molecules. First showcased 
with naked DNA in 2005 by Guan J. et. al., DNA can not only be combed into 
aligned and ordered arrays, but they can be transferred onto a separate 
substrate via in a technique known as transfer printing.[19] In transfer printing, 
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DNA is combed on a polymer stamp that contains the patterned microwells and 
before the stamp face is contacted to a silanized surface. The method is simple 
to perform requiring very little equipment set up and robust, serving as an 
effective means of elongating DNA.[20-21] For these reason, our group has 
previously used this method to demonstrated epigenetic imaging of 
methylation sites on bacteria lambda phage DNA as shown in figure 3.1 
below.[22] Here, methyl-CpG-binding domain (MBD) peptide that has been 
fluorescently labeled with Alexa Fluor 488 dye is used to tag CpG dinucleotides 
for identification upon fluorescence imaging.  
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Figure 3.1 – Imaging DNA Methylation with MBD Peptide on DNA Arrays 
(Adapted from Cerf A. et. al., 2011) 
Molecular combing in junction with contact transfer printing is used to elongate λ-
DNA molecules and immobilize them on silanized glass cover slip. (Row 1) 
Unmethylated DNA is used as a control and shows no non-specific MBD peptide 
binding. (Row 2) Methylated DNA is combed and visible under the wavelengths 
exciting the MBD labels. The combined image shows methylation sites (red) in addition 
to the naked DNA (green). (Row 3) Shows the combed molecules from a 1:1 mixture of 
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methylated and unmethylated DNA. Expectedly, some molecules are not present when 
exciting under 475nm (emission 535nm) due to the lack of methylation sites on those 
molecules.  
 
Coupled with high-resolution imaging such as total internal reflect (TIRF) 
microscopy or localization microscopy, molecular combed DNA labeled with 
fluorescent tags may reach sufficient spatial resolution for direct imaging-based 
DNA methylation mapping.[23-25] To then demonstrate the potential for this 
technique to serve as a high-throughput sequence independent platform for 
epigenetic mapping of chromatin, we transposed these methods to native 
human chromatin derived from cancer cells and then labelled for various 
histone modifications.  
 
 
3.2  MATERIALS AND METHODS 
 
3.2.1  Polymer Microwell Stamp Fabrication 
 
Microwell patterns were etched in standard 4-inch silicon wafers with a mask 
containing 9 identical stamps arranged in a 3 x 3 grid aligned to the center of 
the mask. Each stamp contains arrays of 5μm and 8μm diameter circles spaced 
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in with varying distances between wells ranging 15μm or 20μm apart 
depending on the region of the stamp. Since combing selects for molecules 
within certain size ranges, these different patterns maximize the likelihood of 
combing success for a wider range of molecule sizes. Using the ABM Near-UV 
Vacuum Contact Aligner, the pattern from the mask was transferred to the 
resist spun onto the silicon wafer. The resist was then stripped and the wafer 
was etched in a Unaxis SLR 770 Deep Si Etcher for 15 cycles. Height of the 
resulting pillars on the silicon master was measured using a P-10 profilometer. 
These posts serve as a negative mold for polymer mold casting the microwell 
array polymer stamps. Polydimethylsiloxane (PDMS) was mixed at a ratio of 
10:1 and poured onto the silicon master until a 0.5cm thick layer of PDMS was 
achieved. The PDMS was then baked in a closed oven at 80C for 3 hours. Once 
fully cured, the PDMS slab was peeled off from the wafer and the combing 
stamps were excised from the slab with an X-Acto knife as rectangular stamps 
measuring approximately 1.4cm x 1.8cm. 
 
 
3.2.2  Cell Culture 
 
M0-91 acute myelogenous leukemia cell line cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum 
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(FBS),  1% (vl) Pen-Strep, 1% (vl) Non-essential Amino Acids (NEAA), 1% (vl) 
Sodium Pyruvate, 1% (vl) L-Glutamine 200mM, 2.5% (vl) 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), and 0.1% (vl) of 1% 2-mercaptoethanol 
(β-ME). Media was filtered with a 20μm filter prior to use. Cells were cultured 
in a Sheldon 2350-T incubator set at 37C and 5% CO2 until 70%-80% confluency. 
Cells were split taking aliquots of the M0-91 cells grown in culture and adding 
them directly to fresh media at a 1:50 dilution.  
 
HeLa wild type (HeLa-WT) cervical cancer cell lines cells were cultured in 
identical media as the M0-91 cells for all chromatin combing experiments and 
also allowed to propagate to 70-80% confluency. To passage the cells, cell media 
was aspirated and the cells were washed with 1xPBS that has been set to 37C in 
a water bath. The PBS was aspirated out and 6ml of 0.25% Trypsin was added 
to the T75 culture flask and incubated with the cells at room temperature for 5 
minutes. Cells were gently tapped to release them from surface adhesion and 
trypsin was neutralized with equal volumes cell media. The cell suspension was 
then transferred to a 15ml centrifuge tube and spun at 1000g for 5 minutes. The 
supernatant was discarded and the remaining cell pellet was resuspended in 
5ml of fresh media. The resuspended cells were then aliquoted into new T75 
flasks at a dilution of 1:50.  
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3.2.3  Ultra-Long Native Chromatin Extraction 
 
Prior to extraction, 30ml of chromatin extraction buffer was prepared on ice 
containing 10.2ml 1M sucrose, 0.45ml 1M Tris (base), 0.45ml 1M NaCl, 1.8ml 
1M KCl, 0.3ml 1M CaCl2, 37.5ul 200mM phenylmethylsulfonyl fluoride (PMSF), 
30ul 100% β-ME, 15ul spermidine, and 4.5ul spermine. Each buffer must be pH 
adjusted to pH 8 prior to mixing into chromatin extraction buffer. After mixing 
all components together. Separately, lysis buffer containing 1% Triton-X in 1x 
phosphate buffered saline (PBS) is supplemented with 1 tablet of c0mplete Ultra 
Mini EDTA-free protease inhibitor (Roche) for every 50ml of lysis buffer.  
 
The first step of the extraction procedure is to remove the cells from the T75 
flasks in which they are grown. Since M0-91 cells are non-adherent cells, no 
trypsin is necessary. Cells are transferred into 15ml BD-plastic capped test tubes 
and spun at 1000g for 10 minutes in an Allegra 21R centrifuge. The supernatant 
from the centrifuged test tubes are aspirated and discarded. The remaining cell 
pellet is resuspended in 5ml of lysis buffer and physically shaken to break up 
the cell before placing the eppendorf on ice for 5 minutes. The cell suspension 
was then transferred to a 7ml glass dounce homogenizer and homogenized for 
12 strokes, with an up and down motion of the dounce hammer counting as 2 
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strokes. After homogenization, the lysis buffer and lysed cell suspension within 
the dounce is transferred aliquoted into 1.5ml eppendorf tubes with a 
maximum volume of 1ml per tube. The eppendorf tubes containing the M0-91 
chromatin, cellular debris, and lysis buffer was then placed in an IEC Micromax 
centrifuge and spun at 10,000g for 10minutes. The supernatant from each 
eppendorf tube was carefully aspirated out with a P-200 micropipette and the 
remaining pellet, which is the M0-91 chromatin, was resuspended in chromatin 
extraction buffer prepared above. 
 
The chromatin extraction process relies on a balance between chemical and 
mechanical lysis to extract chromatin while maintaining nucleosome integrity. 
1% Triton-X serves to lyse the cellular membrane while keeping the nuclear 
envelope intact. Chemicals able to dissolve the nuclear envelope are far too 
harsh for maintaining the nucleosomes, and thus the mechanical shear forces 
generated by the dounce homogenizer is meant to create tears in the nuclear 
envelope. Thus, the chromatin must be given time to diffuse out of the ripped 
nuclear envelopes. This process can take up to two weeks for ultra-long 
chromatin. Alternatively, if shorter chromatin fragments are desired, the 
diffusion time can be shortened by digesting the chromatin contained within 
the torn nuclear envelopes with micrococcal nuclease for until a desired size 
range is yielded and then heat inactivating the enzyme.  
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3.2.4  Histone Antibody Labeling 
 
1:200 dilution of monoclonal mouse histone H3 primary antibody MABI 0301 
(Active Motif) was incubated with 2ug of native chromatin for 1 hour at room 
temperature. AlexaFluor647-tagged goat anti-mouse IgG secondary antibody 
(Invitrogen) was then incubated with the sample at 1:200 dilution for an 
additional 30 minutes in the absence of light. This process was repeated for 
histone H3K9me2 labeling using H3K9me2 rabbit antibody (Active Motif) and 
AlexaFluor488-tagged anti-rabbit IgG secondary antibody (Invitrogen). The 
histone labeled chromatin samples were then incubated with 1:10,000 YOYO-1 
intercalating dye (Invitrogen) or 1:200 DAPI (4',6-Diamidino-2-Phenylindole, 
Dihydrochloride) (ThermoFisher Scientific) for 1 hour at room temperature also 
in the absence of light. 
 
 
3.2.5  Chromatin Arrays Molecular Combing 
 
PDMS stamps containing the microwell array patterns were fabricated as 
described in previous sections of the methods and used within minutes of 
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peeling the stamp off of the master as to prevent dust adsorbance onto the 
surface. All combing was performed at room temperature under the absence of 
light to prevent potential photobleaching of any fluorescent labels on the 
chromatin. The setup for the combing process involves a mechanically 
translating stage that is controlled by a Newport 861 motion controller and an 
adjustable lever arm attached to a glass slide.  
 
To begin, a PDMS stamp is laid flat on the surface of the translating stage while 
under no motion. A 15ul droplet containing chromatin at 200ng ul-1 is loaded 
onto the surface of the stamp towards one of the axial ends of the stamp via a 
P-200 micropipette. The stamp orientation is determined by the 1.4 x 1.8 
dimension with the longer axis aligned to the direction of combing. One half of 
a 180μm thick glass cover slip with the dimensions of a standard microscope 
slide is then adhered onto an adjustable lever arm. This lever arm is placed 
along the opposing end of the direction of combing and the glass cover slip is 
carefully manually lowered onto the PDMS surface until the chromatin droplet 
has made contact with the glass. The cover slip is then further lowered until 
there is a sub-1mm gap remaining between the stamp and the cover slip, 
allowing the droplet containing the chromatin sample to spread out and span 
the entire width of the stamp. When these processes have been completed, the 
sample is considered to be loaded. 
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An illustration of the operational procedures is shown in figure 3.2 below. 
Briefly, once the sample of native chromatin has been loaded, the stage upon 
which the PDMS stamp sits is mechanically translated away from the position 
of the lever arm at a constant velocity of 20μm s-1 until the cover slip, that once 
overlapped the stamp, is no longer overlapping the stamp. The surface charge 
of the glass coverslip allows the sample to more favorably reside on the 
coverslip surface rather than the hydrophobic PDMS surface throughout the 
entire combing process. As the stamp is translated away from the cover slip that 
is held by the lever arm, the liquid contact line is swept over the entire PDMS 
stamp face. As the liquid-air interface passes over the patterned microwells, a 
combination of its velocity, the liquid contact angle, and local evaporation 
causes chromatin molecules within the solution to become pinned within the 
microwell. The pinned molecule is then elongated as the interface is pulled 
across the microwell and remaining is the chromatin molecule in a linearized 
configuration on the stamp surface. Once combing was completed, the 
chromatin arrays arrested on the surface of the PDMS stamp was then 
transferred onto a Fisherbrand 22x22-1 glass cover slip (Fisher Scientific) 
following the Microcontact transfer printing protocols outlined in the following 
section.  
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Figure 3.2 – Chromatin Molecular Combing Operational Procedure and 
Experimental Setup 
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(A) A 15ul droplet of sample containing chromatin (black lines floating in the liquid) is 
loaded onto a PDMS 0.5cm thick PDMS stamp via micropipette. (B) A glass slide is 
then lowered onto the droplet, sandwiching the droplet and spreading the liquid to span 
a wider area of coverage. (C) As the stage supporting the polymer stamp is translated 
away from the position of the fixed glass cover slip, the sample travels with the 
hydrophilic glass surface instead of the hydrophobic stamp surface. This causes the 
droplet to be dragged over the patterned microarrays on the stamp and during this 
process, a combination of forces including edge evaporation (red arrows) causes the 
chromatin molecules to be pinned within microwells. (D) As the fluid front passes over 
the microwell array, pinned chromatin molecules are pulled and elongated onto the 
stamp surface. (E) Top-down view of the experimental setup on an optical table. Here, 
the adjustable lever arm can be rotated or locked with a hex key and the PDMS stamp 
would be loaded onto the black colored slab on the stage. Z-position of both the stage and 
lever arm can be adjusted. 
 
 
3.2.6  Chromatin Microcontact Transfer Printing 
 
Platinum Line 24mm x 60mm cover glass was sonicated for 4 cycles alternating 
between immersed in 100% ethanol and 1M KOH beginning with KOH and 
ending with ethanol cycle. The cover glass was kept in ethanol until use, and 
washed again with 100% ethanol and dried with bone-dry grade nitrogen gas. 
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Cleaned cover slips were treated for 5 minutes with oxygen plasma using a 
Harrick Plasma Cleaner. After oxygen plasma treatment, cover slips were 
immediately submerged in a beaker containing 1% APTES, 5% water, and 94% 
ethanol. After one hour, cover slips were removed from the beaker, gently 
rinsed with 100% ethanol first and then 100% water before being dried with 
nitrogen gas. Finally, the now silanized glass cover slips were placed on a hot 
plate set to 150C for 10 minutes. To microcontact transfer print the chromosome 
arrays, one edge of the silanized surface of the glass cover slip was contacted 
with the PDMS stamp containing the post-combed chromatin arrays. The cover 
slip was then carefully laid onto the cover slip by motion of hinged door as to 
prevent air bubble pockets. Full contact between the stamp and cover glass was 
visually confirmed and gentle pressure was applied to the marriage for 60 
seconds before subsequently peeling the stamp off of the cover glass.  
 
 
3.2.7  Chromatin Fragment Size Characterization 
 
Chromatin extractions were characterized by gel electrophoresis after 
micrococcal nuclease digestion and removing histones via phenol chloroform 
extraction and ethanol precipitation. This was done to validate nucleosome 
integrity post-extraction. 300ul aliquots of chromatin obtained from the 
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chromatin extraction protocol outlined in above sections were digested with 1ul 
of 1:10 diluted micrococcal nuclease (2000 gel units) for times ranging from 5 
minutes to 30 minutes. Separate tubes were digested for different times 
spanning 5 minute intervals per tube and enzymatic reactions were then 
neutralized with 35ul of 0.5M EDTA. Digested chromatin samples were then 
supplemented with 100ul 1%SDS, 100% neutral phenol, and 100% chloroform. 
The mixture was vortexed vigorously for 30 seconds and then spun at 10,000g 
for 5 minutes. The upper phase was carefully transferred into fresh 1.5ml 
eppendorf tubes. Equal volumes of 100% ethanol and 3.5ul of 3M NaOAc was 
added to the tube. The tube was centrifuged at 14,000 rpm in an Eppendorf 5424 
centrifuge for 30 minutes while set at 4C. The supernatant was then removed 
and the pellet was gently washed with 70% ethanol in water. Finally, the 
washing solution was also aspirated out and the pellet was allowed to air dry 
for 1 hour before being resuspended in 300ul of 1x Tris-EDTA (TE) buffer. 500ng 
of the DNA was then ran on a 1.8% agarose gel at a constant voltage of 80V for 
40 minutes. The gel was stained with 1:10,000 SYBR-Gold dye (ThermoFisher 
Scientific) on a rocking platform for 1 hour and imaged on a Kodak EDAS-290 
UV lamp. Atomic force microscopy (AFM) characterization was performed 
with a Dimension 3000-1 AFM (Digital Instruments) using tapping mode at 
80Hz and 512-line resolution.  
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3.3  RESULTS 
 
3.3.1  Combing Characterization with Lambda Phage DNA  
 
The protocol for chromatin molecular combing and microcontact transfer 
printing was developed and optimized on λ-DNA due to it being robust and 
easy to purchase. Lambda DNA contains 48,502 base pairs (bp) and with the 
theoretical length of each bp being 0.3nm, lambda should extend 14.55μm in 
length when fully elongated.[26] Lambda DNA stained with YOYO-1 
intercalating dye was combed using the microwell pattern developed. Combing 
λ-DNA yielded a few interesting results. Firstly, an ideal concentration of DNA 
in solution prior to combing was determined to be 10ng to 30ng ul-1. Much 
higher concentrations result in multiple fibers of DNA being bundled together 
and an inability to resolve single molecules. This decreases the accuracy of any 
potential genomic or epigenomic mapping applications as it becomes more 
difficult to determine which strand an observed mark of interest is originating 
from. Next, out of the various well sizes on a single stamp patterned area, 
multiple well sizes were observed to be able to trap and elongate λ-DNA during 
the combing process, however microwells spaced less 5μm apart and 
50 
 
microwells under 10μm in diameter were observed to exhibit poor trapping 
efficiencies. Examples of these phenomena are shown in figure 3.3 below.  
 
 
 
 
Figure 3.3 – Arrays of Lambda Phage DNA Molecular Combing Micrographs 
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(A) 2,000ng ul-1 λ-DNA combed on a PDMS stamp yields significant bundling and 
intertwining DNA molecules. (B) 25μm well diameter sizes with 10μm separation 
distance successfully combs and elongates λ-DNA as well as (C) 10μm well diameter 
sizes with a 15μm spacing. (D) A few molecules at the end of an array are elongated 
past the contour length of 14.55μm extending up to maximum observed length of 
31.36μm. (Combing direction from right to left.)  
 
Another observation of interest is that molecules at the end of the array can 
extend to longer lengths than 14.55μm. This suggests either stretching beyond 
the contour length or that there are multiple molecules intertwined and the 
observed strand is not a single molecule.[26] The former is entirely a possibility 
as due to the motion of the liquid front passing over the combing wells. In brief, 
the liquid front contours around a microwell until the meniscus force exceeds 
the pinning force and the liquid front snaps for a short distance and is caught 
on the next microwell as it repeats the contouring process. At the end of the 
array, the final snapping of the liquid front is not caught by another well and 
thus the snapping speed may be faster than throughout the rest of the array 
thereby stretching the λ-DNA molecule beyond its 14.5μm contour length. The 
alternative possibility of multiple molecules being combed in each well is not 
mutually exclusive with regards to the first scenario. To verify that chromatin 
molecules combed were single molecules rather than ropes, AFM was used to 
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characterize nucleosome and DNA backbone height. Using Image-J, the 
average measured λ-DNA strand length was 12.95μm (n=25) corresponding to 
an 89% extension, which is comparable to molecular combing directly on 
silanized glass.  
 
 
3.3.2  Native Chromatin Extraction Characterization  
 
Nucleosome integrity of native chromatin extractions were first verified with 
micrococcal nuclease digestion followed by gel electrophoresis to check for the 
presence of banding patterns. The micrococcal enzyme is a non-site specific 
endonuclease that cleaves DNA at random points. With chromatin, the enzyme 
will cleave around nucleosomes but are physically unable to access the DNA 
bound wrapped around a nucleosome whereas with bare DNA, the enzyme can 
cleave anywhere on the length of the molecule.[27-28] Thus, random cleaving 
from micrococcal nuclease on intact chromatin will leave a distribution of size 
fragments shown as distinct bands in an electrophoresis gel. These bands 
indicate post-digestion chromosome fragments of differing nucleosome count. 
If the chromosome does not contain intact nucleosomes, a smear is created as 
the micrococcal nuclease enzyme is no longer restricted to cleaving at any 
location along the molecule. Figure 3.4 below shows the results we obtained 
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from the native M0-91 and HeLa chromatin extractions post micrococcal 
treatment.  
 
 
 
 
Figure 3.4 – Sizing Micrococcal Digested Chromatin on Gel 
(Modified from Cerf A. et. al., 2012) 
Banding patterns are visible after micrococcal digestion of native chromatin extractions 
for chromatin extracted from both M0-91 cells as well as HeLa-WT cells. 
 
Combed chromatin was transfer printed onto silanized cover slips and 
characterized with AFM. The height of the nucleosomes on the combed native 
chromatin was measured to be 10.4nm ±1.8nm and the height of the DNA 
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backbone measured 1.76nm ±0.38nm. These results are in accordance with 
theoretical values of nucleosomes, 10nm, as well as bare DNA, 2nm.[29] Thus, 
this suggests that the chromatin combing and transfer printing process isolated 
single molecules rather than bundled ropes. Furthermore, the AFM images 
shown in figure 3.5 below confirm the integrity of the nucleosomes as validated 
by the gel studies.  
 
 
 
 
Figure 3.5 – AFM Imaging and Characterization of Combed Chromatin  
(Modified from Cerf A. et. al., 2012) 
(A) Chromatin arrays visible on AFM from large area scan identified by the red arrow 
markers. The white dotted line indicates the field of view shown in (B), where Z-axis 
analysis reveals that the nucleosome height and DNA backbone height correspond to 
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theoretical values thereby confirming the chromatin molecule observed is a single 
molecule.  
 
 
3.3.3  Imaging Histones and Epigenetic Marks on Chromatin Arrays 
 
Native chromatin samples pre-labeled with fluorescent antibodies bound to 
histone H3 were combed and imaged with a 100X oil-immersion lens on an IX-
70 Olympus Inverted Microscope (Olympus). By labeling the DNA backbone 
with a separate color dye as to not cause spectral overlap, histone H3 can be 
visualized on native chromatin. This can be seen in figure 3.6 below with M0-91 
native chromatin that has been combed into an array. The DNA backbone 
imaged at 488nm is compiled with the histone H3 image taken at 650nm to form 
a composite image transposing histone positions on the elongated 
chromosomal DNA. To verify that the AlexaFluor647-tagged secondary 
antibody bound to the primary histone H3 antibody specifically, secondary 
antibody was incubated with native chromatin in the absence of the primary 
antibody. We found very minimal instances of non-specific secondary antibody 
binding to the combed chromatin despite taking no additional steps to wash 
away unbound or non-specifically bound secondary antibody after molecular 
combing or transfer printing. We then took one step further to demonstrate the 
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labeling of epigenetic histone modifications on combed native M0-91 chromatin 
with a 3-color colocalization between the DNA backbone, histone H3, and 
H3K9me2 as shown in figure 3.7.   
 
 
 
 
Figure 3.6 – Imaging Histone H3 on M0-91 Native Chromatin Arrays 
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(Modified from Cerf A. et. al., 2012) 
(A) Native chromatin extracted from M0-91 cell line labeled with YOYO-1 
intercalating dye allows for the fluorescence imaging of the DNA backbone. (B) The 
same field of view with AlexaFluor647 labeled histone H3 positions. (C) Composite 
images showing colocalization of histone H3 (red) on the DNA backbone (green). (D) 
Taken from a separate experiment where secondary antibody was incubated with M0-
91 chromatin in the absence of primary antibody to show lack of non-specific binding. 
(Combing direction from top to bottom.)  
 
 
 
 
Figure 3.7 – Fluorescently Tagged Antibody Labeling of Histones and 
Epigenetic Modifications on Native Chromatin Arrays 
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Here, the chromosomal DNA backbone was labeled with DAPI dye, histone H3 was 
labeled with AlexaFluor647, and H3K9me2 was labeled with AlexaFluor488. All three 
labels can be seen in a colocalized image with combed M0-91 native chromatin. 
(Combing direction from right to left.) 
 
A correlation was noted between the site of antibody tagged histones and an 
increased fluorescence intensity of the DNA backbone as stained with 
intercalating dye. We postulate this could be the result of a number of factors, 
the first of which is that at each labeled histone site there would be a higher 
spatial concentration of DNA accounted for by the DNA wrapping around the 
nucleosome. However, varying fluorescence intensities between these 
nucleosome sites may suggest a higher order structure as opposed to a perfectly 
linearized beads-on-a-string chromatin fragment. Possibilities include a kink or 
knot in the chromatin molecules combed, an observation that has been made by 
others on phage DNA when combing at various speeds and pH on silanized 
glass.[30-31] Alternatively, it is possible that although AFM results have shown 
our ability to comb single chromatin molecules, the fluorescence micrographs 
taken in figure 3.6 and figure 3.7 are of chromatin bundles rather than single 
molecules. To further elucidate these theories, it is critical to move beyond 
diffraction limited imaging. Coupling chromatin combing with localization 
microscopy techniques such as Stochastic Optical Reconstruction Microscopy 
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(STORM) is essential to achieve resolution scales required to accurately 
determine histone modification position and nucleosome distribution.  
 
 
3.4  ALTERNATIVE LINEARIZAITON TECHNIQUES EXPLORED 
 
Alternative native chromatin immobilization techniques were explored upon 
achieving chromatin extraction lengths of over 500kb. The motivation for 
extracting ultra-long beads-on-a-string chromatin was for lowering the 
required amount of input sample for optical mapping. Conventionally, optical 
mapping requires strands of DNA or chromatin to be pieced together by 
overlapping regions. By reducing the sum of overlapping regions necessary to 
reproduce the genome through increasing strand lengths, less input material is 
required. Among a number of linearization techniques explored including 
capillary flow cells and droplet drying, shear flow yielded the best results for 
elongation of ultra-long native chromatin. Here, a 15ul droplet of sample 
containing the ultra-long chromatin is micropipetted onto a 22mm x 22mm 
glass cover slip. Another cover slip of the same dimensions is then laid directly 
on top of the sample droplet thereby squeezing the contents of the droplet to 
span the entire area in between the top and bottom cover slips. This creates a 
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hydrodynamic shear force that extends molecules in solution as shown with 
chromatin extracted from HeLa-GFP cells in figure 3.8 below.  
 
 
 
 
Figure 3.8 – Ultra-Long Native HeLa-GFP Chromatin Elongated via Shear 
Flow Between Glass Coverslips   
Native chromatin extracted from HeLa-GFP cell lines expressing green fluorescent 
protein (green) labeled with BOBO-3 intercalating dye (red). These ultra-long 
fragments span a minimum of 500 kb to upwards of 1.3 Mb and are elongated via shear 
flow. 
 
Unfortunately, all alternative linearization techniques explored were less 
reliable in comparison to patterned array molecular combing. Challenges 
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include severe molecule bundling as well as often an increased background 
fluorescence. One advantage associate with molecular combing on a 
hydrophobic polymer stamp was that as combing occurred, unbound dye 
traveled with the fluid rather than remaining on the surface. In techniques such 
as droplet drying and shear flow, free dye in solution was not washed out 
thereby causing an often high level of background fluorescence. On the other 
hand, flow cell techniques suffered heavily from incomplete elongation. 
Although these issues encountered for the alternative techniques explored 
could be ameliorated with extensive parameter optimization, it was ultimately 
decided to be too unreliable as a platform for mapping based diagnostic.  
 
 
3.5  CONCLUSION 
 
The ability to molecular comb native chromatin molecules derived from human 
cells holds significant implications towards potential medical diagnostics based 
on rapid assessment and mapping of a patient’s epigenome. To this end, we 
have taken the first steps in applying molecular combing and transfer printing 
to native chromatin molecules extracted from human cancer cell lines M0-91 
and HeLa. Furthermore, we have demonstrated the ability to fluorescently tag 
both histones as well as histone modifications for high resolution imaging. We 
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show the ability to colocalize multiple fluorescent tags on single chromatin 
molecules however, moving past diffraction-limited optics is necessary to 
improving mapping accuracy. Still, challenges remain in correlating chromatin 
molecule lengths as measured with microscopy to a base pair count. This is 
because unlike bare DNA, the DNA in chromatin is wrapped around 
irregularly spaced nucleosomes. Furthermore, as the DNA naturally only 
wrapped 1.65 turns around a nucleosome rather than one or two full turns, 
predicting the degree of unraveling caused by fully extending the molecule for 
each nucleosome is a significant challenge. Together, these challenges represent 
some of the shortcomings of an optical based mapping as applied to chromatin. 
Nonetheless, we have shown the first steps towards the overall greater effort of 
enabling rapid epigenome mapping based on direct visual interrogation of 
native mammalian chromatin.  
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CHAPTER 4   
MICROFLUIDIC DEVICE FOR CELL PROCESSING, DNA EXTRACTION, 
AND IN-CHANNEL IMAGING 
 
 
4.1 INTRODUCTION 
 
While direct approaches to genomic and epigenomic mapping covered in 
previous chapters are being explored as alternatives to well-established 
techniques, they require a large amount of cellular input. As a result, these 
direct mapping approaches become unsuitable when considering diagnostic 
applications with limited starting material. One such application is genetic and 
epigenetic analysis of circulating tumor cells (CTCs). CTCs are highly 
malignant cancer cells known for their ability to translocate through the 
endothelial linings of blood vessel walls and their ability to survive undetected 
in the blood stream.[1-3] By these means, CTCs from one tumor site can migrate 
throughout the vasculature and exit to seed satellite tumors in separate organs 
or tissues. This process, known as metastasis, is responsible for over 90% of 
cancer related deaths in humans.[4] Thus, understanding the unique properties 
67 
 
of a patient’s CTCs, such as the genetic and epigenetic profile, may lead to 
improved cancer diagnostics and treatments.[5]  
 
However, reliably isolating CTCs remains challenging due to their ultra-low 
frequency. Found in our bodies at concentrations of only 1 to 10 cells per 
milliliter of whole blood, analyzing CTCs becomes impractical with many 
existing technologies that require thousands or even hundreds of cells as 
input.[6] To this end, numerous microfabricated technologies have been 
developed for single cell capture and isolation of nucleic acids as preparation 
for analysis platforms such as sequencing.[7-12] Of the microfabricated 
technologies that are capable of single cell DNA extraction and purification 
from few cells, most do so through solid phase extraction (SPE).  
 
In SPE based techniques, DNA is purified by selective binding to functionalized 
surfaces, such as that of microbeads, and then washing out the cell lysate. 
Although these mechanisms can be easily integrated with a wide range of single 
cell isolation techniques such as fluorescence activated cell sorting (FACS), the 
process ultimately relies on the binding interaction between the solid phase 
matrices and the target DNA. Despite a number of recent advances made to 
improve the binding affinity between the DNA and matrix such as by adjusting 
buffer composition, pH, and temperature, it is still a fundamentally equilibrium 
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driven interaction where DNA loss is likely.[13-15] Furthermore, binding 
between the solid phase matrices and DNA can be subject to interference by 
proteins and cellular debris contained within the lysate. Consequently, SPE 
based methods have only achieved DNA extraction efficiencies of between 50% 
and 80%.[16-19] Although this recovery efficiency may be sufficient for genomic 
analysis of cell populations, the limited gene copies available within a single 
cell requires a higher precision approach.  
 
In this chapter, we describe a single integrated microfluidic device capable of 
single cell and small cell population capture, DNA extraction, purification, in-
channel labeling, in-channel imaging, and off-chip collection. The device 
presented is a simple two port, valveless, PDMS microfluidic chip that operates 
based on using a micropillar array to achieve the aforementioned capabilities. 
Although microfabricated obstacle arrays have been extensively studied as 
applied to DNA size filtration and linearize, cellular genomic DNA extraction 
using micropillar array has yet to be demonstrated. Unlike SPE-based methods, 
micropillar array DNA extraction is a purely physical process that does not 
require any DNA binding or surface functionalization. Here, we use the 
micropillar array based microfluidic device to extract and purify DNA from 
varying cell counts of human cancer cell lines. We assess off-chip collection of 
the extracted DNA and measure extraction efficiency through fluorescence 
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quantification and qPCR. Finally, we also test in-channel epigenetic 
modification labeling and imaging.  
 
4.2 MATERIALS AND METHODS 
 
4.2.1  Microfluidic Device Fabrication 
 
Illustrated by the workflow in figure 4.1, silicon molds for polydimethylsiloxane 
(PDMS) microfluidic devices were fabricated using standard photolithography 
techniques. Briefly, wafers (Ultrasil; Hayward, CA) were spin coated with 
Microposit S1813 photoresist (Shipley; Marlborough, MA). Device pattern was 
transferred onto photoresist layer using UV contact lithography (ABM contact 
aligner, ABM-USA; San Jose, CA). Exposed substrates were developed in 
726MIF developer (Microchemicals). The microfluidic pattern was transferred 
onto the top silicon layer by Bosch process in a Unaxis SLR 770 deep reactive 
ion etching system (Unaxis USA Inc.; St. Petersburg, FL). Etch depth was 
determined to be 20 – 25 µm using a P10 profilometer (KLA Tencor; Milipitas, 
CA) and a Zygo otical profilometer (Zygo Corporation; Middlefield, CT). A 
monolayer of (1H,1H,2H,2H-Perfluorooctyl) Trichlorosilane was deposited on 
the etched wafers in a MVD100 molecular wafer deposition system (Applied 
Microstructures; San Jose, CA) to prevent adhesion of PDMS to the mold.  
70 
 
 
Sylgard 184 (Dow Corning; Midland, MI) PDMS base resin was mixed with the 
curing agent at a 10:1 ratio, degassed under vacuum at room temperature, 
poured onto the master until a 1cm thick layer was achieved, and then heat 
cured for 45 minutes at 150C. The elastomer casting was then peeled off the 
mold and access holes to the input and outputs of the microchannels were 
created via 1.5mm biopsy punch (Sklar Instruments; West Chester, PA). To 
complete channel fabrication, the patterned PDMS was treated with oxygen 
plasma for 5 minute and bonded to a 500 μm thick fused silica wafer (Mark 
Optics; Santa Ana, CA).  
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Figure 4.1 – Microfluidic Device Photolithography Process Outline 
Starting with a clean 4-inch diameter silicon wafer surface (A) photoresist (yellow) is 
spin coated onto the surface (B). The pattern is then exposed and developed (C) before 
the photoresist is stripped and the wafer is the wafer is etched (D). To prevent polymer 
binding on the surface during mold-casting, a thin layer of FOTS is vapor deposited 
onto the silicon master (E). To fabricate the polymer microfluidic device, PDMS base 
mixed with curing agent is poured onto the silicon master (F). After removing the cured 
silicon slab containing the pattern (G), it is then plasma bonded onto a glass silica wafer 
to create the final microfluidic device (H).  
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4.2.2  Cell Culture 
 
Myeloid leukemia cell line M0-91 and cervical cancer cell line HeLa wild type 
cells were cultured in the same conditions outlined in section 3.2.2 of Chapter 
3. Prior to introduction into the channel, M0-91 cell lines were taken directly 
from an 80%-90% confluency culture flask containing media and diluted 1:50 
into 1x PBS buffer. Similarly, for HeLa-WT cells post trypsinizing, cell pellets 
were resuspended in 5ml of 1x PBS buffer and further diluted at 1:50 in 1x PBS 
buffer prior. To help prevent cell adherence onto the inner walls of the 
microfluidic channels, the devices were primed with 1% BSA at room 
temperature for 2 hours prior to the addition of cells.  
 
 
4.2.3  Microfluidic device operation 
 
The microfluidic device was first treated with 5 minutes of oxygen plasma using 
a Harrick Plasma Cleaner to facilitate initial channel priming. 20ul of 100% 
ethanol was used to prime the device immediately after oxygen plasma 
cleaning. The device was then secured to the stage of an Olympus IX71 
microscope via masking tape with channels above the objective. Hard plastic 
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PEEK 1/16th inch OD Tubing (Upchurch Scientific) was connected to an empty 
Hamilton 81110 glass 0.25ml syringe (Hamilton) via plastic flange fittings (JL 
White). 100% H2O was manually pulled into the syringe through the PEEK 
tubing until there was approximately 50ul within the syringe. The syringe was 
mounted on a PHD Ultra Pump (Harvard Apparatus) and secured via the 
pump’s inbuilt syringe clamps. The water was infused out of the PEEK tubing 
until a 10ul droplet formed at the output before inserting the tubing into the 
output port of the microfluidic device. In this step, extra care was taken to 
ensure a droplet-to-droplet connection was made as to not introduce any air 
bubbles into the microfluidic system. After tube insertion, the pump was set to 
withdraw mode at 60nl min-1 and water was flown into the microfluidic device 
for 5 minutes. The input port was then loaded with priming buffer consisting 
of 1x PBS and 1% bovine serum albumin (BSA) for 2 hours to block the inner 
channel walls from nonspecific protein adhesion of the cells. Next, channel was 
flushed with 1x PBS buffer for 5 minutes. Cells were loaded into the device 
again via the input port. Images of captured cells were taken at this time along 
with inspecting the length of the device to ensure no randomly adhered cells 
were lodged either upstream or downstream of the cell capture region. Lysis 
buffer consisting of 1% (wt) sodium dodecyl sulfate (SDS) surfactant in PBS was 
flowed into the channel at a constant speed of 15nl min-1 for a total of 5 minutes 
to lyse the cells. In contrast to DNA extraction, chromatin extraction was 
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performed with a different lysis buffer, containing 1% (vl) Triton-X in 1x PBS 
rather than using any SDS. In either case, the lysis buffer was then washed out 
of the channels by flowing water for into the device 10 minutes. The device and 
the entrapped DNA or chromatin is now ready for imaging or off-chip 
collection following the procedures described in the following sections. 
 
 
4.2.4  In-Channel Imaging of DNA and Chromatin 
 
DNA was imaged with a number of different intercalating dyes. To image the 
DNA with SYBR-Gold intercalating dye (Invitrogen), 1:10,000 dilution of SYBR-
Gold dye was prepared in 1x TE buffer at room temperature and flowed into 
the channel for a minimum of 20 minutes in the absence of light prior to 
fluorescence imaging. Similarly, SYBR-Green intercalating dye (Invitrogen) was 
also used in various experiments to stain DNA following the same protocols as 
SYBR-Gold dye. Alternatively, Quant-iT PicoGreen intercalating dye (Thermo 
Fisher Scientific) has also been used to stain bare DNA by diluting the dye at 
1:200 in 1x TE buffer. PicoGreen dye was flowed into the channel for a minimum 
of 15 minutes in the absence of light prior to imaging.  
 
75 
 
Histone H3 labeling of in-channel chromatin was done with Histone H3 
(Abcam) fluorescently conjugated with Alexa Fluor 647 using a protein labeling 
kit (Thermo Fisher Scientific). The antibody was flowed into the channel at a 
concentration of 1.5ug ml-1 in priming buffer supplemented with 0.05% Tween-
20 and incubated for one hour. Excess and unbound antibody was washed out 
of the channel prior to imaging. Similarly, H3K9me2 was labeled with Alexa 
Fluor 647 conjugated H3K9me2 Antibody (Abcam) and incubated for an hour 
before imaging as well. A concentration of 10 ug ml-1 was used for H3K9me2 in 
the priming buffer with 0.05% Tween-20. To calibrate the fluorescence intensity 
for fluorescence based quantification of H3 or H3K9me2, Cy5 dye was imaged 
at 30nM and 30μM concentrations in blank channels free of cells and biological 
materials.  
 
 
4.2.5  Off-Chip DNA Collection and Quantification 
 
In order to extract the DNA from its entangled state within the microfluidic 
device, it must be enzymatically cleaved and released downstream. 1ul of BAM-
HI enzyme (New England BioLabs) was diluted in 100ul of Buffer 2 (New 
England BioLabs) and preheated to 37C in a water bath. The enzyme was then 
loaded into the input port of the microfluidic device and flowed at a rate of 
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100nl min-1. To keep the reaction as close to 37C as possible, the microfluidic 
device was heated via heat gun (Master). Fragmented DNA was collected into 
the 0.25ml syringe and then transferred into a 1.5ml eppendorf tube. DNA was 
fluorescently stained with PicoGreen dye at a 1:200 dilution and then quantified 
via a NanoDrop 3300 Fluorospectrometer (NanoDrop). Calibration curves for 
the fluorospectrometer were generated using identical staining protocols with 
a series dilution of T4 bacteriophage DNA (100ng ml-1, 50ng ml-1, 25ng ml-1, 
12.5ng ml-1, 6.25ng ml-1, and 3.13ng ml-1). Measures were blanked with a 
background set by 1:200 dilution of PicoGreen in water.  
 
For experiments pertaining to the qPCR, M0-91 gDNA standards were obtained 
from phenol chloroform bulk-extraction of 2 x 106 M0-91 cells. The DNA was 
further purified via ethanol precipitation and stored in 1x TE buffer at 4C until 
use. To create qPCR DNA standards, the bulk-extracted M0-91 gDNA was 
diluted to samples with a DNA mass of 3.3pg, 6.6pg, and 9.9pg. DNA extracted 
from single M0-91 cells on chip was released via enzymatic cleaving with Hind-
III at 37C for 1 hour. Hind-III was then heat inactivated by submerging the 
collected sample in 65C water bath for 10 minutes. Whole genome amplification 
was completed with the Single Cell WGA kit (New England BioLabs). qPCR 
was performed with a LightCycler 480 Real-Time PCR thermocycler (Roche).  
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4.3 RESULTS 
 
4.3.1  Micropillar Array Channel Design 
 
The micropillar array in the device served dual purposes of both size-based cell 
capture as well as entrapment of DNA and chromatin upon cell lysis by means 
of physical entanglement. Shown in figure 4.2 below, various dimensions and 
designs of the micropillar region were explored including progressively higher 
density pillars, random pillar placement, and changing the channels widths to 
accommodate different cell counts.  
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Figure 4.2 – Cell Capture and DNA Extraction Region Designs 
(A) Zoomed out crop of the microfluidic channel design consisting of an input port 
(left), output port (right), and tapered narrow channels leading into and out of the 
micropillar array region where cell capture and DNA extraction takes place. (B) A 
250μm wide channel with progressively denser spaced (15μm spacing down to 2μm 
spacing) micropillars. (B) A 500μm wide channel made to accommodate larger cell 
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counts. (C) Randomized pillar arrangement design as an alternative to the ordered 
arrays design was tested for its ability to increase DNA capture efficiency.  
 
Support pillars 15μm in diameter were spaced sparsely upstream of micropillar 
arrays to prevent channel collapse from the negative pressure generated by the 
withdraw of the syringe pump. Smaller micropillars spanned 5μm in diameter 
and at the highest density configuration, were spaced only 2μm apart from one 
another. The channel leading into and out of the device was tapered to a 
narrower width canals to increase flow rate of the cells from the input port to 
the micropillar capture region while reducing collision velocity once the cells 
entered into the broader regions of the channel where the pillar array was 
located. However, we later found that the support structures in the constricted 
narrower channel regions leading into and out of the micropillar array region 
often caused undesired cell adhesion, collision, and DNA entanglement. In all 
of the micropillar configurations tested across devices, the arrangement of 5μm 
diameter microposts with respect to one another held no visible impact on the 
DNA capture capabilities.  
 
Various designs for the regions immediately downstream adjacent to the cell 
capture and DNA extraction micropillar arrays were also explored as shown in 
figure 4.3. The reason for doing so is that our original design consisted of 
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extending the tightly packed pillar array all the way until the tapered output 
canals but we found that for longer channels, extended lengths of highly dense 
micropillar arrays began to impede the hydrodynamic flow rates within the 
channel. Alternative designs were explored with the effort to have the pillars 
downstream of the cell capture and DNA extraction region act as both support 
structures to prevent channel collapse as well as points of electrostatic contact 
for strands of DNA that are tethered upstream. However, we observed no 
change to the tethering behavior or extraction capabilities of the DNA extraction 
region by removing these downstream structures in later iterations of the 
microfluidic device.  
 
 
  
 
Figure 4.3 – Downstream Micropillar Configuration Designs 
(A) Dense micropillar arrays extended fully downstream impedes flow rate at longer 
channel lengths. (B) Alternative design with clusters of 4 micropillars spaced in a 
diamond aligned in rows of 5 periodically spaced downstream of the main cell capture 
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and DNA extraction regions. (C) Staggered pillars aligned in periodic rows to help 
provide additional points of electrostatic contact for DNA molecules suspended 
upstream.  
 
When mold-casting the PDMS slab to create the microfluidic device, we 
observed that the speed at which the cured PDMS was peeled from the silicon 
master had the potential to affect the final channels. Peeling the PDMS from the 
device too quickly was detrimental in that many micropillars would be ripped 
from the PDMS slab and remain lodged within the features of the silicon master, 
as shown by figure 4.4, thereby rendering that silicon master unfit for further 
mold-casting. This issue was alleviated by vapor depositing a monolayer of 
fluoroalkylsilane FOTS on the silicon master after photolithography.  
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Figure 4.4 – Micropillar Stripping in Failed Devices 
Peeling the PDMS slab from the silicon master often causes micropillars to be stripped 
and lodged within the silicon mold. Silicon masters were coated with FOTS to help 
prevent this occurrence.  
 
Lastly, because smaller features etch slower than larger features in 
photolithography, taller channel designs of heights exceeding 25μm often 
exhibited micropillars that were unable to reach the floor of the device as 
depicted by figure 4.5. This produced the effect of cells being able to deform and 
migrate through the PDMS pillars unimpeded at higher flow rates. A 
combination of lower channel heights, softer PDMS made from higher base-to-
curing agent mixing ratios, and slower flow rates of less than 3ul min-1 were 
used to combat this problem. Additionally, pressure was applied to clamp the 
PDMS slab to the glass after plasma bonding to further aid the pillars in making 
contact with the glass surface.  
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Figure 4.5 – Cells Squeezing Between the Micropillars and Glass on Devices 
with Heights Exceeding 25μm  
(A) M0-91 cells trapped in the micropillar array on a device with micropillars that reach 
all the way to the glass. (B) Aspect ratio dependent etching rate of silicon mold resulting 
in micropillars that were too short thus allowing M0-91 cells to pass under them 
resulting in failed cell capture. (In both panels, fluidic flow moves from the direction of 
left to right). 
 
 
4.3.2  DNA Extraction and Staining 
 
The unique novelty of our microfluidic device is DNA capture upon cell lysis 
through physical entanglement. This process is done in complete absence of any 
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chemical modifications to the cell, DNA, or to the inner channel walls of the 
device. Relying solely on the size of the DNA molecules, the micropillar array 
entangles the DNA much similar to how spaghetti may become entangled on a 
fork. As the surfactant within the lysis buffer denatures the histones packing 
the DNA into higher order structures, the DNA unravels in solution as it 
collides into downstream pillars causing the tethering. This tethering can occur 
in a number of different configurations as shown in figure 4.6 below. Due to the 
ratio between gDNA length and our micropillar diameters, the most common 
configuration for the tethered DNA likely resembles a molecule that is tethered 
at multiple locations and folding on itself.  
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Figure 4.6 – Illustration of gDNA Tethering Configurations within 
Micropillar Array Post Cell Lysis 
This figure represents DNA tethered on the micropillars post cell lysis in a micropillar 
array device where flow is moving in the direction from left to right. The simplest 
tethering configuration (orange) would be a molecule that is tethered at one point by a 
single micropillar. A variation of this configuration is if a molecule is folded on itself 
either once or a multiple of times yet is still tethered by a single micropillar (purple). 
The most likely scenario given the scale of the DNA molecules is that there are multiple 
levels of folding events and multiple micropillars upon which a single DNA molecule 
can be arrested.  
 
Furthermore, smaller molecules such as RNA, lipids, proteins, and other 
cellular debris is washed away downstream leaving only the genomic DNA 
(gDNA) tethered on the micropillars. By this process, the extracted gDNA is 
also purified without the need for downstream or off-chip filtration. 
Furthermore, the local environment of the DNA can be controlled within our 
microfluidic system by simply exchanging the input fluid into our device. The 
tethered DNA can then be stained with fluorescent intercalating dyes such as 
SYBR dyes or PicoGreen dye. As shown in figure 4.7, DNA from each individual 
cell trapped within the pillar array becomes entangled just downstream of the 
original position of the cell prior to the introduction of lysis buffer. Depending 
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on cell count, the amount of extracted DNA tethered to the pillars can be either 
visualized as individually resolvable strands or a meshed web. 
 
 
 
 
Figure 4.7 – DNA Extraction from 4 and 100+ Cells Using 250μm and 500μm 
Width Microfluidic Channels  
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(A) Four M0-91 cells are trapped within the less spatially dense cell capture region of 
the micropillar array. (B) The DNA from the four cells shown (positions denoted by 
yellow dotted line circles) in (A) are tethered on the pillars downstream after cell lysis 
and are visible through PicoGreen staining and fluorescence imaging. Individual DNA 
strands are visibly entangled around microposts. (C) 100+ M0-91 cells trapped in the 
cell capture region of a larger microchannel. (D) Web of DNA taken extracted from the 
cells shown in (C) fill the channel downstream of the cell capture region. (In all panels, 
fluidic flow moves from the direction of left to right). 
 
 
When loading cells into the device at concentrations of above 104 cells ml-1 we 
encountered many cases of cells becoming adhered onto the upstream support 
pillars. As seen in figure 4.8 below, these support pillars often trapped cells prior 
to the micropillar array and acted to entangle the DNA from those upstream 
cells during lysis. One possible issue with such events is that the lack of pillar 
density around the support structures may cause significant loss of gDNA 
during lysis, thereby inaccurately skewing cell count vs trapped DNA. Such 
was our reasoning for later removing upstream support structures and opting 
for narrower channels when redesigning our microfluidic channels for single 
cell experiments.  
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Figure 4.8 – Unintended Cell Trapping and DNA Tethering by Upstream 
Support Structures  
(A) Cells can become adhered or trapped on upstream support structures prior to 
entering the micropillar array regions which then causes (B) DNA tethering on support 
structures upon cell lysis. (In both panels, fluidic flow moves from the direction of left 
to right).  
 
 
4.3.3  Off-Chip DNA Fluorescence Quantification 
 
To ensure that we were not losing significant quantities of DNA through the 
micropillar array DNA extraction process, we used enzymatic digestion of the 
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Bam-HI restriction endonuclease to cleave and release the tethered gDNA, 
collected it off-chip, and quantified the yield through fluorospectrometer. We 
first created a calibration curve for our NanoDrop 3300 fluorospectrometer 
through a series dilution of bacteriophage T4 DNA at 100ng, 50ng, 25ng, 12.5ng, 
6.25ng, and 3.125ng ml-1 as shown in figure 4.9 below.  
 
 
 
 
Figure 4.9 – T4 DNA Based Fluorospectrometer Calibration 
N=23 for each DNA concentration in the series dilution of T4 DNA. Data taken on a 
NanoDrop 3300 fluorospectrometer with 2.5ul droplets for each measurement. Baseline 
fluorescence calibrated with water (n=25).  
 
90 
 
To collect the extracted gDNA off-chip, restriction endonuclease Bam-HI was 
flowed into the device to cleave and release the tethered DNA. Due to the high 
concentrations of enzyme used, DNA cleaving and release occurred rapidly 
reaching completion in under 10 minutes. This process was observable in real-
time by fluorescently staining the tethered DNA with intercalating dye and 
imaging the micropillar arrays during the cleaving process. In figure 4.10 below, 
gDNA extracted from M0-91 cells that have been fluorescently stained with 
PicoGreen intercalating dye. Within two minutes, all of the DNA originally 
tethered on the micropillars during the extraction process has been cleaved and 
released downstream. 
 
 
 
 
Figure 4.10 – DNA Release from Micropillars via Enzymatic Digestion 
Fluorescently stained DNA extracted from 66 M0-91 cells are cleaved with restriction 
endonuclease Bam-HI and released downstream to be collected and quantified off-chip. 
The area being observed is the microfluidic pillar array region containing the tethered 
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gDNA. Time stamps of the frame taken from a real-time video are labeled on the 
corresponding panel. (In all panels, fluidic flow moves from the direction of right to left). 
 
The enzymatically cleaved DNA can then be collected in the microfluidic 
output and then quantified via fluorospectrometer by referencing 
measurements against the calibration curve we derived in figure 4.9. By being 
careful not to contaminate flow-through from the cell lysis stage of the process, 
we were able to remain confident that the DNA collected from enzymatic 
accurately represented only the gDNA tethered upon our pillars. We then 
repeated the process of cell capture, gDNA extraction, enzyme digestion, off-
chip collection, and mass measurement for varying cell counts. Since we wanted 
to evaluate the sensitivity of our device for the purposes of eventual single cell 
DNA extractions, we chose to analyze low cell count populations of less than 
100 cells. Assuming the human genome contains approximately 3 billion bases, 
diploid cells would theoretically contain 6.6pg of DNA.[20] This can then be 
used to evaluate our microfluidic device extraction efficiency by comparing our 
mass of DNA collected versus original cell count prior to cell lysis. As shown in 
figure 4.11 below, we obtained a cell mass of 6.7 ±0.2pg per cell across all 
samples.  
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Figure 4.11 – Extracted DNA Mass vs Cell Count 
Six different cell counts tested for populations of less than 100 cells. Mass was measured 
via fluorescence intensity on fluorospectrometer and determined with T4 DNA 
calibration curve. Horizontal error bars represent dead cells that were present in the 
micropillar array during cell lysis that could have skewed total DNA mass.  
 
Possible explanations for why our measured values exceed the theoretical value 
could stem from biological reasons such as that M0-91 may be hyperploid as 
are many malignant cell types. Another explanation for the mismatch between 
measured and theoretical DNA mass per cell may be due to errors in cell 
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counting. In higher cell count samples, many dead cells, identified by their 
significantly smaller sizes, were often present. Yet, depending on the stage of 
cell death, DNA may have either completely undergone apoptosis and be too 
fragmented to become tethered on the micropillars or they may still be 
relatively in-tact, in which case accounting for their DNA would increase the 
measured total DNA mass for that given sample. Control experiment using 
over-cultured dead M0-91 cells showed no DNA capture on micropillar array, 
confirming DNA fragmentation during apoptosis. Thus, the potential error 
attributed to dead cell count is represented by the horizontal error bars seen in 
figure 4.11 above. Here, although the reproducibility of the NanoDrop 3300 
measurements were low, leading to a wider range of data for each extraction, 
our overall assessment is that our microfluidic device is capable of high 
efficiency DNA capture with little to no DNA loss.  
 
 
4.3.4  Single Cell DNA Extraction and qPCR  
 
In the realm of single cell analysis, sample loss during DNA extraction or 
purification equates directly to an incomplete target genome. Although this 
scenario can be mitigated in population level analysis due to the presence of 
many genome copies, having at maximum only two copies of each gene in a 
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single cell requires DNA handling platforms with much higher precision. To 
evaluate the suitability of our microfluidic device as it applies to single cell 
analysis, we analyzed single cell DNA capture efficiency with quantitative 
polymerase chain reaction (qPCR). First, by significantly diluting the 
concentration of cells prior to loading them into the channel, we were able to 
load single cells into our microfluidic channel as shown in figure 4.12 below. 
 
 
 
Figure 4.12 – Single Cell Entrapped Within Micropillar Array  
(A) Single M0-91 cell lodged within the cell capture region of the micropillar array. (B) 
Zoom-in of the area cropped in (A) taken with a 20x objective lens highlighting the 
single cell within the yellow circle. (In all panels, fluidic flow moves from the direction 
of left to right). 
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Captured single cells were lysed in our device following identical protocols 
from the previously described multi-cellular DNA extraction and off-chip 
collection methods. Bulk-extracted M0-91 gDNA was diluted to three separate 
DNA mass standards of 3.3pg, 6.6pg, and 9.9pg and then whole genome 
amplified with qPCR. The resulting amplification curves are shown in figure 
4.13 below.  
 
 
 
 
Figure 4.13 – Measured qPCR Fluorescence Intensity versus Cycle Number 
Cp value measured for single M0-91 cell DNA on-chip extraction was 7.4. Cp values 
from DNA standards of 3.3pg, 6.6pg, and 9.9pg were 6, 9, and 11 respectively. Blank 
control samples with no DNA had a measured Cp value of 14.  
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Cp values for 3.3pg, 6.6pg, and 9.9pg of DNA was measured to be 6, 9, and 11 
respectively. Additionally, qPCR performed on a blank sample of water in the 
absence of DNA resulted in a Cp of 14. A linear fit was created for Cp value 
measured versus pre-amplification DNA mass based on the bulk-extracted M0-
91 DNA standards and blank sample as shown in figure 4.14 below. The single 
M0-91 cell on-chip extracted DNA sample Cp measured at 7.4 was then plotted 
against this linear fit to derive the starting DNA mass prior to amplification.  
 
 
 
 
Figure 4.14 – Measured Cp versus Pre-Amplification DNA Mass 
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Six different cell counts tested for populations of less than 100 cells. Mass was measured 
via fluorescence intensity on fluorospectrometer and determined with T4 DNA 
calibration curve. Horizontal error bars represent dead cells that were present in the 
micropillar array during cell lysis that could have skewed total DNA mass.  
 
In the plot of Cp versus DNA mass, the slope of the linear fit through the DNA 
standards measured with bulk-extracted DNA was -0.8 ±1 with an R2 value of 
0.988. Through plotting the single cell Cp value of 7.4 along the fit, we 
determined the original single cell in the microfluidic extraction to have 
contained 8 ±1pg of DNA. The fact that our measured single cell DNA mass 
exceeds the theoretical value of 6.6pg could be a result of two factors. The first 
is that we did not control for cell cycle phase in our experiments and if the single 
cell that we sampled was in S phase, it is undergoing constant DNA replication 
in preparation for the G2 phase and cellular division and thus would skew our 
measured DNA mass.[21] The second factor is that as chromosomal 
hyperploidy is one of the most common cytogenetic aberrations found in acute 
myeloid leukemia cells, in which case extra chromosomes present in the original 
may be the culprit behind the higher than theoretical measured DNA mass.[22-
23]  
 
 
98 
 
4.3.5  In-Channel H3K9me2 Fluorescence Quantification 
 
Chromatin extraction and imaging in-channel was briefly explored with HeLa 
cells for the purposes of fluorescence based epigenetic mark quantification. In 
these experiments, varying cell counts of human cervical cancer HeLa cells were 
loaded into the microfluidic channel and lysed with a 1% Triton-X buffer. This 
softer surfactant allowed for permeabilization of the cellular membrane without 
stripping the nucleosomes from the chromatin as would be the case with using 
a harsher surfactant such as SDS. As 1% Triton-X leaves the nuclear envelope 
undissolved, the majority of chromatin within the lysed cells becomes tethered 
by the nucleus rather than within the micropillar array. This chromatin can then 
be hybridized with fluorescently tagged antibodies specific to histones and 
epigenetic histone modifications. In figure 4.15 below, chromatin from HeLa 
cells lysed with Triton-X are incubated with H3K9me2 specific antibodies 
before subsequently also being labeled with H3 specific antibodies.  
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Figure 4.15 – H3 and H3K9me2 Antibody Labeling on Extracted HeLa 
Chromatin In-Channel 
(A) 52 HeLa cells immobilized within the cell capture region of the micropillar array. 
(B) Post-lysis with 1% Triton-X in 1x PBS. Cell walls have visibility been 
permeabilized but cellular structures are still visible within the pillar array indicating 
non-complete dissolving of the nuclear envelope. (C) Chromatin labeled with anti-
H3K9me2 antibody tagged with Alexa Fluor 647. (D) After washing out unbound anti-
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H3K9me2 antibody, AlexaFluor647-tagged anti-H3 antibody was flowed into the 
channel to label all histone H3s. (In all panels, fluidic flow moves from the direction of 
left to right). 
 
The total measured fluorescence intensity values were then corrected for the 
protein-to-dye ratio which was 1 and 3 for H3K9me2 and H3 respectively. By 
then taking the corrected fluorescence intensity of H3K9me2 as a fraction of the 
corrected histone H3 fluorescence intensity, we were able to fluorescently 
quantify the frequency of H3K9me2 within a group of cells. Furthermore, for 
cells sufficiently spaced apart, our microfluidic platform allowed us to identify 
H3K9me2 modification frequency on a single cell basis. Although in our 
experiments, both histone H3 and H3K9me2 modification were labeled with 
Alexa Fluor 647, we reason this did not affect fluorescence intensity 
measurements of either H3K9me2 or histone H3. This is because we labeled the 
rarer H3K9me2 marks prior to labeling all histone H3 thus incorporating the 
fluorescence of the H3K9me2 marks into the histone H3 fluorescence 
measurements. When we took this approach to then measure the H3K9me2 
frequency in 75 HeLa cells across 15 experiments, we found an average 
H3K9me2 frequency of 2.9 ±0.9% which was in accordance with the 2.6 ±0.1% 
frequency reported by Voigt P. et. al., 2012.[24] These results are shown in figure 
4.17 below.  
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Figure 4.16 – H3K9me2 Frequency versus HeLa Cell Count  
Frequency of H3K9me2 as a percentage of total histones per cell measured in 75 cells 
across 15 separate microfluidic experiments where HeLa wild type cell chromatin was 
extracted and fluorescently antibody-labeled. Largest cell count performed in a single 
experiment was 38 HeLa cells, which resulted in a measured H3K9me2 frequency 
similar to the 75-cell average.  
 
Finally, to confirm that the fluorescence events imaged were a result of target 
specific antibody binding rather than non-specific dye binding, IgG was 
conjugated with Alexa Fluor 647 dye and flowed into our device post chromatin 
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extraction. Results as shown in figure 4.18 validate the specificity of our 
antibodies and lack of non-specific Alexa Fluor 647 binding events.  
 
 
 
 
Figure 4.17 – IgG Tagged with Alexa Fluor 647 as a Control for HeLa 
Chromatin Labeling  
(A) 49 HeLa cells immobilized within the cell capture region of the micropillar array. 
(B) AlexaFluor647-tagged IgG incubated with the extracted chromatin show no visible 
nonspecific binding. (C) AlexaFluor647-tagged H3 antibody flowed in after washing 
out IgG shows that all Alexa Fluor 647 staining is specific to the target and not a result 
of non-specific dye binding. (In all panels, fluidic flow moves from the direction of left 
to right).  
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4.4 ALTERNATIVE DEVICE DESIGNS EXPLORED 
 
Several alternative device designs were explored in the process of iterating and 
improving the performance and function of the device. From these alternative 
designs we were able to draw conclusions between design parameters and their 
effects on device performance. On such alternative design explored was a 
shorter micropillar array region length. In this iteration, the motivation to 
shortening the pillar array region was for condensing microfluidic channel real-
estate. However, as shown in figure 4.19, shorter pillar array regions are unable 
to contain the entire length of the extracted gDNA from a group of cells. In this 
case, DNA can be observed to be seen tethered within the tapered region of the 
channels leading into the output port and in many cases is visible within the 
output port. DNA was observed to be tethered on the downstream support 
structures rather than within the micropillar array indicating potential DNA 
loss during the extraction process as the density of the support structures is 
much lower than that of the micropillar array.  
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Figure 4.18 – Short Micropillar Arrays Unable to Retain Full Length of 
Extracted gDNA  
(A) Micrograph of a shorter micropillar array region channel geometry. (B) Extracted 
gDNA from cells loaded into the pillar array region shown in (A). Here, DNA can be 
clearly seen tethered on support structures beyond the micropillar array. (C) gDNA 
stained with fluorescent intercalating dye seen extending past the pillar array region 
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into the tapered region leading to the output port. (D) gDNA seen extending into the 
output port and upwards in the z-axis into the output tubing. (In all panels, fluidic flow 
moves from the direction of left to right). 
 
To remediate the short channel lengths, the micropillar array region was 
extended into a 10cm long region that folded on itself in an ‘S’ shape. The idea 
of this design was to allow for the longest human chromosome, chromosome 1 
containing 249 million base pairs stretching roughly 8.5cm from end-to-end, to 
fully fit within the micropillar array unfolded. Unfortunately, this design was 
found to be unnecessary as the extracted DNA very rarely extended past 1cm. 
Furthermore, there were challenges in evenly staining the entire length of the 
pillar array region in the snaking channels. Finally, the large area covered by 
the micropillar array made small pillar diameters impractical in the CAD design 
process. In the end, longer micropillar array regions were adopted for the 
device design, but channels were kept linear in geometry and under 2cm in 
length.  
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4.5  CONCLUSION 
 
In this chapter, we described a device for DNA extraction of single or multiple 
cells by physical entrapment using micropillar arrays. The DNA extraction 
process uses chemical lysis to dissolve the cellular membrane and nuclear 
envelope. As the histone proteins are denatured during lysis, the chromosomal 
DNA can unravel into a lower order structure. In this stage, the genomic DNA 
traveling downstream with the flow become physically entangled on the 
downstream micropillars. This entanglement can occur in a number of different 
configurations, however, as the short length scales of the tethered DNA 
observed within our micropillar arrays strongly suggest the possibility of 
multiple tethering points across multiple micropillars for each strand of gDNA 
as opposed to gDNA tethered on a single micropillar at a single location along 
each molecule.   
 
The extracted DNA was collected off-chip by in-channel enzymatic release, a 
process that can be expanded into future integration of our device with 
downstream DNA processing or analysis platforms. DNA collected from 
various cell counts were measured via fluorospectrometer. From this, we 
determined that we are capable of achieving 100% extraction efficiency with the 
micropillar array. We then used qPCR to analyze our single cell DNA extraction 
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efficiency and demonstrated that we extracted 8pg of DNA, comparable to the 
theoretical mass of 6.6pg found in human diploid cells. Finally, we used our 
device as an imaging platform to quantify the frequency of specific histone 
modifications by using antibody labeling.  
 
The uniqueness of our single cell DNA extraction device versus existing single 
cell processing devices lie in our simplicity of design. Our microfluidic device 
contains no valving, chambering, or peristaltic pumping. DNA tethered within 
our device can be purified by hydrodynamic flow. We do not rely on chemical 
surface modification to capture the genomic DNA and we have demonstrated 
that micropillar arrays can be used to extract DNA from both single cells as well 
as multi-cells populations.  
 
In the next chapter, we modify our micropillar array device design to increase 
the throughput 10-fold and tailor the channels for single cell capture. Having 
shown that we are capable of high efficiency DNA extraction from single cells, 
we explore isothermal whole genome amplification of tethered genomic DNA 
extracted from single cells.  
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CHAPTER 5   
SINGLE CELL WHOLE GENOME AMPLIFICAITON  
VIA MICROPILLAR ARRAYS 
 
 
5.1  ABSTRACT 
 
Single cell whole genome amplification (WGA) has long suffered from 
amplification biases that reduce the accuracy of single cell sequencing data. To 
this end, an easily adoptable process requiring minimal microfabrication 
complexity remains desirable. Here, we describe genomic amplification via 
micropillar array (GAMA) on single human cancer cells from the HeLa cell line. 
This micropillar array is designed to capture single cells and physically entangle 
its chromosomal DNA in a fixed position throughout WGA. By testing for the 
presence of 6 gene loci along the human genome, we demonstrate an improved 
genome coverage and reduced amplification bias using GAMA as opposed to 
conventional fluorescence activated cell-sorting (FACS) based single cell assays. 
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5.2  INTRODUCTION 
 
Single cell analysis has become increasingly important for understanding and 
diagnosing disease.[1-6] For instance, cellular level aberrations have been 
shown to play critical roles in tumor heterogeneity, cancer metastasis, drug 
resistance, and cell fate.[7-12] Investigating these aberrations and 
differentiating between cell types within a population may give rise to 
improved treatments, however, single cell handling and analysis remains 
difficult. Due to having only picogram quantities of DNA, existing workflows 
cannot sequence single cell genomes directly without amplification due to 
sensitivity limits.[13-15] Thus, to obtain a sufficient quantity of material for 
sequencing, single cell WGA is necessary. Among most widely used single cell 
WGA amplification technique is multiple displacement amplification (MDA), 
which relies on a combination of random hexamer primers and the strand-
displacement properties of the Phi29 polymerase to isothermally amplify 
DNA.[14,15] However, the primary technical challenge in using MDA for single 
cell WGA is random amplification bias resulting from chimera formation and 
non-linear enrichment.[16-18] This bias can be averaged out when analyzing 
monodisperse multi-cell population samples due to having a multiple copies of 
each gene. However, biases occurring on the single cell level lead to severe 
underrepresentation of genome regions that were not amplified early-on in the 
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MDA reaction.[19] Figure 5.1 below is an example of fractional genome 
coverage becoming more pronounced as WGA is performed on fewer cells.[31] 
 
 
 
Figure 5.1 – Read Density vs Genome Position from Varying Cell Counts 
(Modified from Ellegaard K. M. et. al., 2014)  
(A) Read density across position is fairly homogenous when sequencing the DNA 
amplified from millions of cells. However, this homogenization begins to deteriorate as 
WGA is performed on fewer and fewer cells with (B) Thousands of cells and (C) 10s of 
cells. (D) Single cell amplified by WGA shows significant fractional genome coverage.  
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To this end, several techniques have been found to minimize amplification bias 
during MDA by reducing reaction volumes.[20] Although the mechanism by 
which reducing amplification volume reduces bias remains to be fully 
explained, it has been demonstrated across a number of platforms. These 
platforms can be broadly categorized into limiting dilution technologies,[21] 
droplet microfluidic technologies,[22-24] and chambered microfluidic 
technologies.[25] Limiting dilution technologies provide a high degree of 
parallelism, but the microwells can suffer from cross-contamination of liquids 
and reagents.[21] More reliable compartmentalization of single cell genomic 
material can be achieved via emulsion enclosure and microfluidic chambers, 
however complex channel geometries and valving systems are required to 
achieve an integrated platform capable of both single cell isolation and genomic 
analysis. Hence, exploring alternative methodologies of integrating cell capture 
and genomic analysis is a critical component of the overall effort to improve 
single cell sequencing.  
 
Recently, our group has developed a valveless microfluidic device for on-chip 
single cell capture and DNA extraction.[26] The core of this technology uses 
micropillar arrays to physically entrap genomic DNA (gDNA) from cells upon 
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lysis. As this process is purely mechanical, it does not require any chemical 
modification or cell sample preparation.  
 
Here, we utilized the unique advantages conferred by micropillar arrays as a 
basis for developing GAMA, a novel microfluidics-based approach towards 
single cell WGA. GAMA relies on the high capture efficiency and DNA 
immobilization properties of micropillar arrays to hold template gDNA in a 
fixed position within the microchannel as reagents for WGA are flowed 
through. This approach differs fundamentally from previously mentioned 
technologies in that the template gDNA is subjected to a constant flow 
throughout the amplification process while the amplified product is washed 
downstream and collected in the output reservoir. To demonstrate the viability 
of our approach, we use GAMA to perform MDA-based WGA of single cells 
and compare the genome coverage, determined by the successful amplification 
of select gene loci, to conventional assays based on fluorescence activated cell 
sorting (FACS). 
 
 
5.3  MATERIALS AND METHODS 
 
5.3.1  Cell Culture 
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HeLa-GFP cells were cultured in Dulbecco’s Modified Eagle medium (DMEM) 
(Invitrogen) within a T75 flask at 37C and 5% CO2. Cell culture medium was 
supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals; Atlanta, 
GA), 1% (wt) non-essential amino acids (NEAA) (Gibco, Life Tecnologies), 1% 
(wt) L-glutamine (Gibco, Life Tecnologies), 2% (wt) HEPES (Quality Biological; 
Gaithersburg, MD), and 0.1% of 1:100 dilution 2-mercaptoethanol (βME) 
(Sigma-Aldrich; St. Louis, MO). Cells were passaged at 60% (vl) confluency 
roughly twice per week. 
 
 
5.3.2  Device Fabrication 
 
General photolithography fabrication steps were done in accordance with the 
methods outlined in section 5.2.2 of Chapter 5. However, PDMS was mixed at 
a ratio of 12:1 base resin to curing agent, rather than 10:1, and was heat cured at 
a lower temperature 100C for one hour in a Sheldon oven. Also, the design of 
the single cell microfluidic channels mask was vastly different than that of the 
original microfluidic pillar array based cell processor. Rather than having a 
single input port lead to a single output port, we increased the throughput of 
the device by splitting the output into 10 separate but identical channels.  
117 
 
 
 
5.3.3  Single Cell Capture and Lysis 
 
HeLa-GFP cells were trypsinized from T75 flasks with 0.25% Trypsin. 
Trypsinized cells neutralized with 1:1 dilution of phosphate buffered saline 
(PBS) buffer, spun down in a centrifuge, and then resuspended in fresh PBS at 
a concentration of 1:50. The cell suspension was flowed into the microfluidic 
device via pressure driven flow at 2 psi with bone-dry nitrogen gas (Airgas; 
Radnor Township, PA). The infusion apparatus was then disconnected from the 
microfluidic device’s input port, washed with alternating cycles of 100% 
ultrapure water (Invitrogen; Carlsbad, CA) and 100% ethanol to remove the 
remaining cells within the reservoir, and then reconnected to the microfluidic 
device input port. Sterile PBS buffer was then flowed into the microfluidic 
device for 5 minutes to allow uncaptured cells to either be captured within the 
cell capture region or to flow through the device into the output reservoirs. The 
output reservoirs of the device were then emptied and rinsed with 100% 
ultrapure water.  
 
Lysis buffer comprised of 6M guanidinium thiocyanate (Sigma-Aldrich; St. 
Louis, MO) in water was flowed into the microfluidic device for 5 minutes also 
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by pressure driven flow at 2 psi. After visually confirming cell lysis in all ten 
channels, the lysis buffer was removed from the input reservoir and the 
reservoir rinsed with 100% ethanol before flushing the entire microfluidic 
device with 100% ethanol for 5 minutes. The ethanol is replaced by washing 
with 100% ultrapure water for 5minutes and then finally replaced by PBS 
buffer. The output reservoirs that now contain a mixture of cell lysates, lysis 
buffer, ethanol, water, and PBS was then emptied and cleaned via rinsing first 
with 100% ethanol and then 100% ultrapure water. The genomic DNA tethered 
within the microfluidic device is now ready for whole genome amplification.   
 
 
5.3.4  On-Chip Whole Genome Amplification 
 
Whole genome amplification (WGA) of the single cell genomic DNA tethered 
within the micropillar array region of the microfluidic device was carried out 
using reagents from the REPLI-g UltraFast Mini Kit (Qiagen; Hilden, Germany). 
Prior to starting the reaction, 280ul of buffer D1 was made by adding 35ul of 
buffer DLB to 245ul of ultrapure H2O. 400ul of buffer N1 was then prepared by 
adding 40ul of stop solution to 360ul of ultrapure H2O. Finally, 288ul of master 
mix was made by adding 18ul of polymerase to 270ul Repli-G UltraFast reaction 
buffer. 
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To denature the double stranded gDNA tethered on the micropillar array, 
buffer D1 was flowed through the device continuously at room temperature for 
8 minutes. Buffer D1 was then removed and the device was flushed with buffer 
N1 for 15 minutes. Afterwards, both the infusion apparatus and the ten output 
reservoirs were emptied and washed with 100% ethanol and then 100% 
ultrapure water. The infusion apparatus was then loaded with the master mix 
solution and pressure was dialed down to 0.5 psi. Pressure was then held 
constant throughout the entire duration of the 3.5 hour reaction amplification 
reaction while the device was placed atop a hot-plate set to 33C. After the 
reaction was completed, 5ul of ultrapure H2O was added to each output 
reservoir. Each output reservoir was then pipette mixed and the solution 
containing amplified genomic DNA was collected off-chip into a polymerase 
chain reaction (PCR) tube. Each output reservoir was then rinsed once more 
with 10ul of ultrapure H2O and the rinse was collected into the respective PCR 
tube containing the amplified product. All samples were placed in a -20C 
freezer until further use. 
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5.3.5  FACS Single Cell WGA 
 
A FACS machine (Becton Dickinson Biosciences; San Jose, CA) was used to sort 
single HeLa-GFP cells into a PCR-compatible microwell plate (Bio-Rad; 
Hercules, CA) with each well containing 5ul of sterile PBS buffer. The microwell 
plate was then spun down in centrifuge at 1000g for 5 minutes to ensure that 
sorted single cells were sitting at the bottom of their respective wells. Buffer D2 
and master mix were then prepared according to the Repli-g UltraFast kit’s 
protocol. To lyse the single cells in each microwell, 5ul of buffer D2 was added 
to each well and incubated on ice for 10 minutes. 5ul of stop solution was then 
added to each well and incubated on ice for 5 minutes. Finally, 53.3ul of master 
mix was added to each well and the microwell plate was placed in a 
thermocycler (Eppendorf; Germany) set to hold at 30C for 3.5 hours.   
 
 
5.3.6  Gene Loci PCR 
 
Primers were designed to target 150bp-200bp regions within six gene loci 
(ERBB2 17q12, PRMT2 21q22, P53 17p13, CCND1 11q13, TRAM1 8q13, and 
MyC8q24) and ordered through Integrated DNA Technologies (IDT; Coralville, 
IA). Lyophilized primers were dissolved in water to a concentration of 10μM. 
121 
 
Then, following the protocols from the Taq DNA Polymerase Kit (Life 
Technologies; Carlsbad, CA), 50ul reaction were prepared for each of the 6 gene 
loci for every collected single cell WGA sample. 30 cycles of PCR were carried 
out and the PCR product was run on a 2.3% agarose gel via electrophoresis. 
Using a 2-log ladder (New England Biosciences; Ipswich, MA), the appropriate 
size region of 100bp-200bp was evaluated for the presence or absence of the 
gene. 
 
 
5.4  RESULTS 
 
5.4.1  Channel Design and Experimental Setup 
 
Figure 5.2 shows the overall experimental setup for GAMA. To create the chip 
device, a slab of mold-casted PDMS (polydimethylsiloxane) imprinted with the 
channel geometry is bonded to a glass slide to create the microfluidic device. 
Reagents are loaded into the device via pressure driven flow from an infusion 
apparatus housing a large fluid reservoir. Fluid that is loaded into the infusion 
reservoir can be easily exchanged and replaced via pipetting. The infusion 
apparatus is a two-part mechanism consisting of a reservoir portion that can be 
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connected to the PDMS and a cap that is connected to the nitrogen gas cylinder 
used to drive channel flow.  
 
 
 
 
Figure 5.2 – GAMA Experimental Setup Overview 
Mold-casted PDMS containing a single input port and 10 parallel output ports are 
bonded to glass silica via oxygen-plasma bonding. An infusion apparatus is connected 
to the input port to provide pressure driven flow of desired fluids. Liquid can be 
manually loaded into the infusion apparatus at will.  
 
Figure 5.3 shows a top down view of the device design. The GAMA device has 
a single input port and 10 separate output ports allowing multiple single cell 
samples to be run in parallel. These ten channels each contain identical designs 
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consisting of a single cell capture region and micropillar array figure 5.3(A). To 
show the device in scale, figure 5.3(B) shows four such devices can be casted 
from a 4-inch silicon wafer mold as a single slab and bonded to a glass-silica 
wafer. Experiments were run with the microfluidic device mounted on the stage 
of an Olympus IX-70 inverted microscope (Olympus; Center Valley, PA) to 
image and observe the microfluidic channels in real time.  
 
 
 
 
Figure 5.3 – 10-Channel Device Geometry and Design 
(A) Device schematic showing valveless 10-channel device design. (B) Picture taken of 
4 separate 10-channel devices made from a single PDMS slab bonded to a 4-inch 
diameter glass silica wafer. (C-E) Chip design variations explored for the bifurcation 
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point with (E) being the final design used. (F-H) Chip design variations explored for 
the individual channel cell capture region explored with (H) being the final design used.  
 
 
5.4.2  Single Cell Whole Genome Amplification On-Chip 
 
As depicted by the graphic in figure 5.5(A), the single cell capture region 
consists of a series of posts arranged in an orientation to allow only a single cell 
to be arrested in the apex of the micropillar array. Barriers surrounding the 
micropillar array prevent non-arrested cells from lodging themselves in the 
micropillar array. Upon introduction of lysis buffer, the micropillar array will 
physically immobilize the gDNA. This immobilization process occurs as a result 
of the chromosomal DNA being physically entangled on the pillars due to their 
centimeter scale lengths, while smaller cellular debris such as lipids, proteins, 
RNA, and mDNA (mitochondrial DNA) are washed away downstream. The 
immobilized gDNA can be imaged via fluorescent staining with DNA 
intercalating dye labels such as with YOYO-1 in figure 5.5(B).  
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Figure 5.4 – GAMA Process Workflow Illustration 
(A) Flow moves from left to right in this schematic and fluids can be exchanged within 
the input reservoir to control the local environment within the channels. (B) Artist 
depiction of a single cell that is trapped within the apex of the micropillar array. Side 
walls enclosing the micropillar array prevent additional cells flowing into the channel 
from having their DNA immobilized within the pillar array. (C) Upon cell lysis, 
genomic DNA from the trapped cell will become entangled in downstream pillars and 
can be visualized via fluorescence staining. (D) Reagents for whole genome 
amplification is flowed into the channel. As amplification occurs, product strands 
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elongate originating from the template, but as they depart from the template genomic 
DNA, they are washed downstream and collected in output reservoirs.   
 
To perform single cell GAMA on the immobilized gDNA tethered within the 
microfluidic chip, we used MDA with reagents from the commercially available 
Repli-G UltraFast Mini Kit (Qiagen). An illustration of the GAMA workflow 
can be seen in figure 5.4 above. After cell capture and lysis, figure 5.4(B) 
denaturation buffer D1 was prepared according to Repli-G kit protocols and 
flowed into the microfluidic device to cleave the hydrogen bonds of the double 
stranded gDNA into single stranded DNA. Buffer D1 was then neutralized by 
flushing the channel with neutralization buffer N1. Finally, the master mix 
containing bases and polymerase was introduced to the channels and the 
microfluidic chip was set atop a heated hot plate to initiate the amplification 
reaction. Although we had initial concerns that denatured DNA molecules 
would rapidly reanneal during the amplification step due to being suspended 
in close proximity to complimentary strands, we saw no evidence of this 
reannealing behavior occurring.  
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Figure 5.5 – Single Cell Capture and DNA Extraction 
Micrograph showing single cell capture (A), and subsequent lysed cell imaged under 
fluorescence with YOYO-1 intercalating dye staining of genomic DNA immobilized 
within the pillar array region (B).  
 
Another concern was that the highly branched structures characteristic of 
isothermal amplification with Phi29 would occlude our channels, however we 
did not observe any buildup or clogging of the device. We reason that this is 
because the average sized fragments produced from the MDA, roughly 12kb in 
length, are too small to wrap around the 1.5μm diameter PDMS micropillars 
without slipping off. Furthermore, the amplification reaction occurs under a 
constant flow, thus, as soon as the amplified fragment is detached from its 
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template strand, it is carried downstream along established flow lines into the 
corresponding output reservoir.  
 
The amplified DNA can then be collected from the output reservoirs and the 
gDNA tethered within the micropillar array can be washed and amplified again 
in further rounds. The advantage conferred from multiple rounds of 
amplification using GAMA is that regions of the genome that are randomly 
overrepresented in one amplification will not carry into the next amplification. 
This is because random amplification bias occurs as a result of the exponential 
growth in the number of fragments in the reaction as the reaction progresses. 
Thus, regions of the genome that are amplified first will quickly pull ahead in 
representation over regions of the genome that are not amplified until later in 
the reaction. With GAMA, the amplified product can be collected while the 
template gDNA is still retained within the channels thereby “resetting” the 
molecule count of the next amplification round. Averaged over multiple 
amplification rounds, GAMA would theoretically remove random 
amplification bias and improve genome coverage. As random amplification 
bias is inherent in single cell MDA, GAMA is a necessary process to obtain full 
genome coverage.  
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5.4.3  Validation and Gene Loci Detection 
 
For the reason that MDA has been shown to produce non-specific product in a 
prolonged reaction, simply quantifying the amount DNA collected from the 
output reservoirs is insufficient to determine the success or failure of the on-
chip single cell GAMA process. To differentiate DNA amplified from gDNA 
versus non-specific product, 6 different gene loci in the human genome were 
selected to act as sampling intervals. Using the product collected from GAMA 
as a template for PCR, the presence or absence of each of the 6 gene loci was 
evaluated as a means of assessing the bias and overall genome coverage of 
GAMA.  
 
Figure 5.7 shows the number of gene loci detected from six single cells amplified 
with GAMA as well as the number of gene loci detected from bulk (107 cells) 
using the same Repli-G UltraFast kit. On-chip negative controls with 0 cells 
expectedly did not amplify any gene loci. Furthermore, as the two main sources 
of potential contamination that may occur are (1) unaccounted cells trapped 
being within the microfluidic channel and (2) off-chip sample handling, we ran 
an experiment where a single device had channels containing both a single cell 
as well as a negative no-cell control. Figure 5.6 shows micrographs taken from 
the cell capture region of the 10 channels in a single device. Channels containing 
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a single HeLa-GFP cell (2, 5, and 7) were compared to channels with 0 cells (1, 
3, and 10) in the number of gene loci detected post GAMA. While it was found 
that many of the gene loci were present in the GAMA product collected from 
single cell channels, 0 gene loci were detected in empty channels on the same 
device. This result eliminates the possibility of on-chip contamination being a 
contributing factor in gene loci detection. Samples from channels such as 
channel 4, 6, 8, and 9 are disregarded due to having multiple cells. Factors 
contributing to the capture of multiple cells within a channel are that the 
channel dimensions and micropillar spacing need to be further optimized for 
the specific cell type being used and rarely, cells become adhered onto the glass 
surface within the device due to non-specific binding. In future iterations of the 
device, non-specific cell adherence can be prevented though treating the glass 
surface with blocking agents or charge-shielding the channel.  
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Figure 5.6 – HeLa-GFP Cell Capture in 10-Channel Device 
Compiled series of micrographs taken from the cell capture region of a single 10-channel 
device. Channels containing single cells (2, 5, &7) are analyzed in comparison to empty 
channels (1, 3, &10), which serve as negative controls from the same device.   
 
 
5.4.4  Single Cell WGA with FACS 
 
To compare our on-chip single cell GAMA results to single cell WGA in absence 
of a micropillar array, we performed Fluorescence Activated Cell Sorting 
(FACS) to isolate various numbers of cells into PCR-compatible 96-well plates 
and amplified the gDNA from these cells using the same reaction times and 
reagents. Our findings, shown in figure 5.7, is that when maintaining the same 
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WGA parameters as GAMA, FACS isolated single cells only amplified one or 
two gene loci compared to the 4 to 6 amplified by the GAMA process. Finally, 
past work has observed MDA to exhibit random bias behaviors on the single 
cell level but non-random bias on a multi-cell level.[13,27-30] Our FACS results 
support this claim as we have observed that biases occurring in samples of 25 
cells consistently underrepresent the same gene loci whereas single cell bias 
showed no such pattern.  
 
 
 
 
Figure 5.7 – Gene Loci Detection of In-Channel versus FACS Single Cell 
WGA Compared with Positive and Negative Controls  
Compiled table of genome coverage analyzed by detection of 6 cancer-relevant gene loci. 
Using GAMA, single cell WGA reflects up to 6/6 gene loci detected versus up to 2/6 
gene loci detected using conventional single cell WGA via FACS. In-channel single cell 
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negative controls with 0 cells expectedly show no gene loci coverage and off-chip bulk-
level analysis affirms the specificity of primers used in loci detection.  
 
 
5.5  CONCLUSION 
 
We have described a micropillar-based microfluidic device capable of on-chip 
single cell processing and WGA. Unlike conventional single cell platforms, 
GAMA is capable of physically separating the template gDNA from the 
amplified product during WGA as well as controlling the fluid environment 
surrounding the gDNA. This property allows GAMA to be used in overcoming 
random amplification bias such as when performing single cell WGA with 
MDA. Here, we have taken the first step to demonstrate a reduced amplification 
bias for single cell WGA using GAMA. This was accomplished by showing that 
we could reliably amplify more gene loci of the genome from single HeLa cells 
using GAMA as opposed to single cells isolated through FACS. In future work, 
we envision being able to use GAMA for multiple rounds of amplification 
performed in series on a single genome template. Doing so would reset the 
product pool molecule count at each intermediate washing step, thereby 
resetting the amplification bias for each round. Subsequently, compiling the 
randomly over-represented regions of each amplification round may serve as a 
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means to improve total genome coverage in bias-vulnerable amplification 
scenarios such as single cell WGA. 
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CHAPTER 6   
CONSLUSION AND FUTURE WORKS 
 
 
6.1  CONCLUSION  
 
Technologies in genetic and epigenetic analysis of DNA and chromatin have 
moved away from relying on indirect methods of analyzing amplified genetic 
material into the realm of directly interrogating the DNA or chromatin molecule 
of interest itself. Most commonly achieved with imaging, platform technologies 
built for the purposes of fluorescence based mapping are often low throughput 
or incompatible with chromatin. Here, we have developed a sequence 
independent high-throughput technique of molecular combing as applied to 
native chromatin and demonstrated labeling and imaging of epigenetic histone 
modifications. However, this technology relies on having many nanograms of 
material for the combing process, making it impractical for cases of rare of 
single cell analysis. To this end, we have designed and developed a micropillar 
array based microfluidic device and a novel WGA approach, GAMA.  
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This microfluidic device and the related GAMA process is unique in its ability 
to retain the original genomic DNA from single cells post cell lysis. Unlike 
existing single cell technologies the GAMA process is fundamentally different 
by three key factors. The first key factor is that unlike microwell based 
technologies, microfluidic chamber technologies, and droplet microfluidic 
technologies where cell lysis and DNA amplification occurs within a single 
compartment, cell lysate is flushed from the microfluidic channels prior to DNA 
amplification. This amounts to a lower concentration of cellular debris 
encountered by amplification reagents during WGA. Furthermore, sequence-
dependent amplification bias resulting from exponential amplification can be 
essentially reset by washing the channel of all amplified material after a round 
of amplification and then initiating a new round of amplification. By doing so, 
certain sequences that are exponentially more represented are unable to affect 
future rounds of amplification. As single cell WGA bias has been observed to 
be random, multiple rounds of WGA on the tethered gDNA from a single cell 
can eventually have the various sequences from each round pooled to overcome 
underrepresented regions of the genome.  
 
The second differentiating factor between GAMA and existing single cell 
technologies is that GAMA performs WGA under constant hydrodynamic flow, 
where the product is washed downstream and separated from the location of 
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the gDNA that is tethered within the pillar array. Here, fluid flow containing 
polymerase, bases, and primers necessary for DNA amplification are constantly 
replenishing the local environment surrounding the tethered DNA in a mode 
of amplification previously unstudied.  
 
Finally, the third differentiating factor stems from the configuration of DNA in 
GAMA versus other techniques. In GAMA, the constant hydrodynamic flow 
during amplification drives tethered DNA molecules within the micropillar 
array to adopt a linearized configuration as opposed to a Brownian-motion 
derived configuration. As such, the gDNA tethered within micropillar arrays 
are more uniformly accessible to polymerases in solution compared to coiled 
DNA in free solution. This increased accessibility may be the reason we 
observed improved genome coverage of single cell WGA using GAMA versus 
single cells that were isolated by FACS and amplified in a 96-well plate.  
 
 
6.2  WHOLE GENOME MULTIPLE AMPLIFICATION 
 
The power of being able to perform multiple rounds of WGA using GAMA 
affords us the ability to study many previously unanswerable questions. The 
first of these questions is whether or not single cell WGA bias is truly random. 
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Currently, amplification bias in single cell whole genome sequencing (WGS) 
occurs as a result of allele dropout during WGA, false sequencing, chimera 
formation, and exponential amplification.[1-6] Although false positives in base 
calling during sequencing can be fixed with higher sequencing depth, allele 
dropout, chimeras, and sequence-dependent amplification bias is an inherent 
part of the current single cell WGA methodologies.  
 
In 2014, deBourcy et. al. found that MDA amplification bias is a function of 
reaction gain, where amplifications beyond 106 results in lower genome 
coverage as shown in figure 6.1.[5] In a separate experiment, the authors 
performed a second round of WGA on the product of the first round, and find 
even more pronounce fractional genome coverage.  
 
 
142 
 
 
 
Figure 6.1 – Single Cell Sequencing Read Density vs Genome Position 
(Modified from de Bourcy et. al., 2014)  
Here, amplification bias is shown to be a function of reaction gain where genomes 
amplified to 106 (red) exhibit less pronounced sequence dependent amplification bias 
than reactions of 109 (orange).  
 
In contrast to running additional rounds of WGA on already amplified product, 
studies such as the one done by Y. Hou et. al. in 2015 shows that if instead a 
second round of WGA is performed on a separate single cell with an identical 
genome as the first cell, they can improve overall coverage of target genome.[2] 
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This is because of one round of WGA on a single cell can be overlaid with 
sequences derived in subsequent rounds to obtain an overall improved genome 
coverage. However, thus far, this principle has only been demonstrated on 
separate aliquots of single cells, and not on a single cell alone. This is for the 
reason that in existing single cell WGA technologies, the gDNA resides in the 
same pool as the amplified material throughout WGA. Thus, after a single 
round of amplification, it is no longer possible to extract the original genomic 
DNA template for a second round of amplification; only WGA on amplified 
product is possible after the first WGA. On the other hand, our single cell 
micropillar array based microfluidic device and the GAMA process is able to 
retain the gDNA template in a fixed position within the microchannels while 
amplified product is washed away and collected in the output. Such a capability 
is especially critical for CTCs where mutations in the genome or epigenome 
may be the cause of cancer aggression.[7-8]  
 
By entrapping single cells within our device, lysing it, extracting the genomic 
DNA, and performing multiple rounds of WGA in succession, we can use DNA 
sequencing or whole genome microarrays to determine the behavior of the bias 
on a single cell basis. In these experiments, if the same genes from the cell are 
present in each round of on-chip WGA, this indicates one of two possibilities: 
either that the bias is not random, or that we have lost a portion of the genome 
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during the extraction process. Additionally, simultaneous to genome coverage 
analysis, multiple rounds of WGA on single cells can be used to characterize the  
 GAMA DNA extraction and WGA process. Numerous studies have shown that 
naked DNA slips off microfabricated pillar arrays when under hydrodynamic 
flow,[9-12] however, this has never been qualitatively observed within our 
device even after remaining suspended by flow for 52 hours. With the speed at 
which slipping occurs being a length dependent process, we can expect longer 
time scales of gDNA tethered within our device to show correlation with gDNA 
loss. Whether this phenomenon is occurring within our device can be 
individually determined by keeping a constant flow rate on extracted DNA and 
regularly collecting and sequencing the output port. Alternatively, this 
information can be analyzed simultaneous to multi-round WGA genome 
coverage analysis by checking for repeated gene early rounds to subsequent 
rounds. Likewise, whether or not template gDNA loss can occur through other 
means such as random physical breakage of the DNA can also be determined 
in a similar fashion.[13-14] Together, the GAMA process and the described 
micropillar array based microfluidic serves as a powerful single cell DNA 
processing and amplification platform.  
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